<SEC-DOCUMENT>0000939767-20-000116.txt : 20200806
<SEC-HEADER>0000939767-20-000116.hdr.sgml : 20200806
<ACCEPTANCE-DATETIME>20200806160948
ACCESSION NUMBER:		0000939767-20-000116
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200806
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200806
DATE AS OF CHANGE:		20200806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXELIXIS, INC.
		CENTRAL INDEX KEY:			0000939767
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				043257395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0101

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30235
		FILM NUMBER:		201081676

	BUSINESS ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		6508377000

	MAIL ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS INC
		DATE OF NAME CHANGE:	20000207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20000106
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>exel8-k20200630earning.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:bcc300cb912b4d33ba6c7433483255c8,x:3995a92986354acfbe3265baef5aaf06-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:exel="http://www.exelixis.com/20200806" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q3FilingDateAug06" name="dei:AmendmentFlag" id="Fact-401B961AA6985EF7BD15776111A0D56B-wk-Fact-401B961AA6985EF7BD15776111A0D56B" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q3FilingDateAug06" name="dei:EntityCentralIndexKey" id="Fact-58AC1E0692B950C78F28784D061C71CC-wk-Fact-58AC1E0692B950C78F28784D061C71CC">0000939767</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="exel-20200806.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q3FilingDateAug06">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000939767</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-08-06</xbrli:startDate>
			<xbrli:endDate>2020-08-06</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="sCA5900A5E1775F41871F3E9B546ECCC1"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:Calibri,sans-serif;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</span></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:16pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:266px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:133px;"></td><td style="width:133px;"></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:2px;text-align:right;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;">FORM </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:2px;text-align:left;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;"><span><ix:nonNumeric id="d8981987e94-wk-Fact-2C45D20106AA56EF9B5F51454828E618" name="dei:DocumentType" contextRef="D2020Q3FilingDateAug06">8-K</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">CURRENT REPORT </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">Date of Report (Date of earliest event reported): </span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d8981987e108-wk-Fact-31DC0C278BDB59F681BEB9F3E9C2AB2D" name="dei:DocumentPeriodEndDate" contextRef="D2020Q3FilingDateAug06" format="ixt:datemonthdayyearen">August 6, 2020</ix:nonNumeric></span></span></span></div><div style="line-height:120%;text-align:center;font-size:16pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:267px;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:266px;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;"><img src="exellogo18q3a18.jpg" alt="exellogo18q3a18.jpg" style="height:49px;width:148px;"></img></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;text-align:center;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;"><span><ix:nonNumeric id="d8981987e127-wk-Fact-71D0F50744515EA98AABF283F3F147D6" name="dei:EntityRegistrantName" contextRef="D2020Q3FilingDateAug06">EXELIXIS, INC.</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(Exact name of registrant as specified in its charter)</span></div></td></tr></table></div></div><div style="line-height:100%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d8981987e151-wk-Fact-0D93A4D652155A60860FA91D1C3EE5C3" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q3FilingDateAug06" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d8981987e156-wk-Fact-910D3B60D22C5E4FA15C58DD78F4D3F9" name="dei:EntityFileNumber" contextRef="D2020Q3FilingDateAug06">000-30235</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d8981987e161-wk-Fact-4F1AB89ADD5550A5AD633F531CB55010" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q3FilingDateAug06">04-3257395</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;text-indent:2px;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(State or Other Jurisdiction of Incorporation)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;text-indent:2px;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(Commission File Number)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;text-indent:2px;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(IRS Employer Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:Calibri,sans-serif;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d8981987e183-wk-Fact-741BB315EDA953958EA7624A26B68686" name="dei:EntityAddressAddressLine1" contextRef="D2020Q3FilingDateAug06"><span style="font-family:Calibri,sans-serif;font-weight:bold;">1851 Harbor Bay Parkway</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d8981987e189-wk-Fact-856643F9E4655AFCBA48159C71ACD934" name="dei:EntityAddressCityOrTown" contextRef="D2020Q3FilingDateAug06"><span style="font-family:Calibri,sans-serif;font-weight:bold;">Alameda</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">, </span><span><ix:nonNumeric id="d8981987e194-wk-Fact-1AD51D73207F5F368B67FD2FBF50B9C2" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q3FilingDateAug06" format="ixt-sec:stateprovnameen"><span style="font-family:Calibri,sans-serif;font-weight:bold;">California</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d8981987e199-wk-Fact-FB2CEC7575C25398920E882786336C84" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q3FilingDateAug06"><span style="font-family:Calibri,sans-serif;font-weight:bold;">94502</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(Address of principal executive offices) (Zip Code)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">(</span><span><ix:nonNumeric id="d8981987e212-wk-Fact-AE1F1691470C5352B96752E27C61E1D4" name="dei:CityAreaCode" contextRef="D2020Q3FilingDateAug06"><span style="font-family:Calibri,sans-serif;font-weight:bold;">650</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">) </span><span><ix:nonNumeric id="d8981987e217-wk-Fact-1653AAFD9CEA547EAAD95A1CB52FAE15" name="dei:LocalPhoneNumber" contextRef="D2020Q3FilingDateAug06"><span style="font-family:Calibri,sans-serif;font-weight:bold;">837-7000</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(Registrant&#8217;s telephone number, including area code) </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span><ix:nonNumeric id="d8981987e229-wk-Fact-C13D1F2B53C35995A1BBF8ED6D545EFD" name="dei:WrittenCommunications" contextRef="D2020Q3FilingDateAug06" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"></span><span style="font-family:Calibri,sans-serif;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span><ix:nonNumeric id="d8981987e237-wk-Fact-617DE8D69BFD557B962C6471FC9106CB" name="dei:SolicitingMaterial" contextRef="D2020Q3FilingDateAug06" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"></span><span style="font-family:Calibri,sans-serif;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span><ix:nonNumeric id="d8981987e245-wk-Fact-4C57964C4F0256A9A62F02015BB73513" name="dei:PreCommencementTenderOffer" contextRef="D2020Q3FilingDateAug06" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"></span><span style="font-family:Calibri,sans-serif;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span><ix:nonNumeric id="d8981987e254-wk-Fact-13C3E43844615BAC92A730C86126DBD3" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q3FilingDateAug06" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"></span><span style="font-family:Calibri,sans-serif;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.62698412698413%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:39%;"></td><td style="width:21%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;text-decoration:underline;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;text-decoration:underline;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;text-decoration:underline;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d8981987e296-wk-Fact-84F4BB7247395BE78194BF4CFDE7D473" name="dei:Security12bTitle" contextRef="D2020Q3FilingDateAug06">Common Stock $.001 Par Value per Share</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d8981987e301-wk-Fact-178448890F8651519B61D5E080700334" name="dei:TradingSymbol" contextRef="D2020Q3FilingDateAug06">EXEL</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d8981987e306-wk-Fact-0AE56F8C60FA53FEA85ADAED52A7A821" name="dei:SecurityExchangeName" contextRef="D2020Q3FilingDateAug06" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company</span><span style="font-family:inherit;font-size:10pt;"> </span><span><ix:nonNumeric id="d8981987e315-wk-Fact-2CC65CA0F8815E1A93F186F2B01D7D37" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q3FilingDateAug06" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sEF35203BDB5E5D8ABB91AFBFB771EB99"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">Item 2.02.  Results of Operations and Financial Condition.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">On </span><span style="font-family:Calibri,sans-serif;font-size:10pt;">August&#160;6, 2020</span><span style="font-family:Calibri,sans-serif;font-size:10pt;">, Exelixis, Inc. (&#8220;Exelixis&#8221;) issued a press release announcing its financial results for the quarter ended </span><span style="font-family:Calibri,sans-serif;font-size:10pt;">July&#160;3, 2020</span><span style="font-family:Calibri,sans-serif;font-size:10pt;">, and providing a corporate update. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">The information in this report, including the exhibit hereto, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Exelixis, whether made before or after the date hereof, regardless of any general incorporation language in such filing. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">Item 9.01.  Financial Statements and Exhibits.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">(d) &#160;&#160;&#160;&#160;Exhibits.</span></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:58%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;font-weight:bold;">Exhibit Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;font-weight:bold;">Exhibit Description</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">99.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exel20200630exhibit991.htm"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Press Release issued August 6, 2020.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.INS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">XBRL Instance Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">The XBRL instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.SCH</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Schema Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.CAL</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.DEF</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.LAB</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Labels Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.PRE</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Cover Page Interactive Data File</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Formatted as Inline XBRL and contained in Exhibit 101.</span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sB3B4E99A76B75DD59BDA57F5F0698C88"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">SIGNATURES </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:71.42857142857143%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="4"></td></tr><tr><td style="width:28%;"></td><td style="width:8%;"></td><td style="width:8%;"></td><td style="width:56%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">E</span><span style="font-family:Calibri,sans-serif;font-size:8pt;">XELIXIS, </span><span style="font-family:Calibri,sans-serif;font-size:10pt;">I</span><span style="font-family:Calibri,sans-serif;font-size:8pt;">NC.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">August&#160;6, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">/s/ J</span><span style="font-family:Calibri,sans-serif;font-size:8pt;">EFFREY</span><span style="font-family:Calibri,sans-serif;font-size:10pt;">&#160;J. H</span><span style="font-family:Calibri,sans-serif;font-size:8pt;">ESSEKIEL</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;font-weight:bold;">Jeffrey J. Hessekiel</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Executive Vice President and General Counsel</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exel20200630exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3C3EF55AFE9D5C8FA89A7125DB679FA5"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.90522243713733%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:29%;"></td><td style="width:37%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:768px;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#ff0000;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div></div><div><br></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;"><img src="exellogo18q3a18.jpg" alt="exellogo18q3a18.jpg" style="height:60px;width:177px;"></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">Contacts:</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Chris Senner</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Chief Financial Officer</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Exelixis, Inc.</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">650-837-7240</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ba6;font-style:italic;text-decoration:underline;">csenner@exelixis.com</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Susan Hubbard</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">EVP, Public Affairs &amp; Investor Relations</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Exelixis, Inc.</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">650-837-8194</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ba6;font-style:italic;text-decoration:underline;">shubbard@exelixis.com</font></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">EXELIXIS </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">ANNOUNCES SECOND QUARTER 2020 FINANCIAL </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">RESULTS AND PROVIDES CORPORATE UPDATE</font></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">- Total Revenues of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">$259.5</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">&#32;Million, Cabozantinib Franchise Revenues of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">$178.7</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">&#32;Million -</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">- GAAP Diluted EPS of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">$0.21</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">, Non-GAAP Diluted EPS of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">$0.25</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">-</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">- Conference Call and Webcast Today at 5:30 PM Eastern Time -</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">ALAMEDA, Calif. - </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">August&#160;6, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">-</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the second quarter of 2020 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial and clinical development milestones.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#8220;Exelixis continued to execute on our key priorities and milestones in the second quarter of 2020,&#8221; said&#160;Michael M. Morrissey, Ph.D., President and Chief Executive Officer of&#160;Exelixis. &#8220;The data flow in the quarter was headlined by the positive top-line results from the phase 3 pivotal CheckMate -9ER study evaluating the combination of cabozantinib and nivolumab in first-line renal cell carcinoma. We&#8217;re looking forward to the presentation of detailed results from the trial at the European Society for Medical Oncology&#8217;s Virtual Congress in September, where CheckMate -9ER has been selected for an oral presentation in the conference&#8217;s Presidential Symposium track. Working in tandem with Bristol Myers Squibb, the trial&#8217;s sponsor, and Ipsen and Takeda, our partners in cabozantinib&#8217;s global clinical development and commercialization, we&#8217;re quickly moving forward with the associated high-priority regulatory filings on a global basis. At the same time, the Exelixis commercial organization is well into their preparations for a potential launch in the United States.&#8221;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Dr. Morrissey continued: &#8220;As we move forward on the next commercial growth opportunity for cabozantinib, we&#8217;re also moving quickly to evaluate its potential utility in additional disease settings. Based on the results from COSMIC-021, we and our collaboration partner Roche recently initiated the CONTACT clinical trial program, which consists of three global phase 3 pivotal trials of cabozantinib in combination with atezolizumab in metastatic non-small cell lung cancer, castration-resistant prostate cancer, and renal cell carcinoma. In addition, as a result of our internal efforts complemented by the work of our research partners, we remain on track to file up to three new Investigational New Drug applications by the end of this year, </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">including a CDK7 inhibitor from our Aurigene collaboration, a tissue factor-targeting&#160;antibody-drug conjugate&#160;from our Iconic collaboration, as well as XL265, a TAM kinase-focused kinase inhibitor from our own laboratories.</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;I&#8217;m proud of the commitment demonstrated by the entire Exelixis team to continue to drive our business forward during these difficult times. We look forward to providing updates on our continued progress throughout the second half of the year.&#8221;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis Second Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">2</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">August 6, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Second Quarter 2020 Financial Results</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Total revenues </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;were </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$259.5 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$240.3 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Total revenues for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;included net product revenues of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$178.7 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$193.7 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The decrease in net product revenues was due to a decrease in sales volume, which was partially offset by an increase in the average net selling price. Net product revenues in the second quarter 2020 were negatively impacted by the COVID-19 pandemic and by an inventory build by wholesalers and end customers in the first quarter 2020, which generally reversed in the second quarter 2020.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Collaboration revenues, composed of license revenues and collaboration services revenues, were </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$80.7 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$46.6 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The increase in collaboration revenues was primarily related to an increase in the recognition of milestone related revenues, increases in development cost reimbursements earned, and higher royalty revenues for the sales of cabozantinib outside of the U.S. generated by Exelixis&#8217; collaboration&#160;partner, Ipsen Pharma SAS (Ipsen).</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Research and development expenses</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;were </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$114.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$81.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The increase in research and development expenses was primarily related to increases in clinical trial costs and personnel expenses, which were partially offset by decreases in license and other collaboration costs. The increase in clinical trial costs was primarily due to costs associated with expanding clinical trial programs for cabozantinib, which includes COSMIC-312, COSMIC-313, CONTACT-02 and COSMIC-021. The increase in personnel expenses was primarily due to an increase in headcount to support Exelixis&#8217; expanding discovery and development efforts. Decreases in license and other collaboration costs were primarily due to upfront license fee payments made in the comparable period of 2019, offset by an increase in research funding commitments in this quarter.&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Selling, general and administrative expenses</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;were </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$59.8 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$58.8 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The increase in selling, general and administrative expenses was primarily related to increases in personnel expenses, which was offset by decreases in marketing costs. The increase in personnel expenses was primarily due to an increase in administrative headcount to support Exelixis&#8217; commercial and research and development organizations</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Provision for income taxes </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;decreased to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$13.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$20.7 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, primarily due to a decrease in pre-tax income.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">GAAP net income </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;was </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$66.8 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.22</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, basic and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.21</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, diluted, compared to GAAP net income of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$79.0 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.26</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, basic and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.25</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, diluted, for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The decrease in GAAP net income was primarily related to an increase in research and development expenses and a decrease in net product revenues, which were partially offset by an increase in collaboration revenues. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Non-GAAP net income </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;was </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$79.4 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.26</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, basic and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.25</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, diluted, compared to non-GAAP net income of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$90.7 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.30</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, basic and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.29</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, diluted, for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. Non-GAAP net income excludes stock-based compensation, adjusted for the related income tax effect.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Cash and investments </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">were</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$1.5 billion</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;at </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">June&#160;30, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$1.4 billion</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;at </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">December&#160;31, 2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis Second Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">3</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">August 6, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Non-GAAP Financial Measures</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">To supplement Exelixis&#8217; financial results presented in accordance with U.S. Generally Accepted Accounting Principles (GAAP), Exelixis presents non-GAAP net income (and the related per share measures), which excludes from GAAP net income (and the related per share measures) stock-based compensation expense, adjusted for the related income tax effect for all periods presented. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis believes that the presentation of these non-GAAP financial measures provides useful supplementary information to, and facilitates additional analysis by, investors. In particular, Exelixis believes that these non-GAAP financial measures, when considered together with its financial information prepared in accordance with GAAP, can enhance investors&#8217; and analysts&#8217; ability to meaningfully compare Exelixis&#8217; results from period to period, and to identify operating trends in Exelixis&#8217; business. Exelixis has excluded stock-based compensation expense, adjusted for the related income tax effect, because it is a non-cash item that may vary significantly from period to period as a result of changes not directly or immediately related to the operational performance for the periods presented. Exelixis also regularly uses these non-GAAP financial measures internally to understand, manage and evaluate its business and to make operating decisions. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">These non-GAAP financial measures are in addition to, not a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. Exelixis encourages investors to carefully consider its results under GAAP, as well as its supplemental non-GAAP financial information and the reconciliation between these presentations, to more fully understand Exelixis&#8217; business. Reconciliations between GAAP and non-GAAP results are presented in the tables of this release.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">2020 Financial Guidance</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis is providing the following updated financial guidance for fiscal year 2020:</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:31%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Total revenues </font><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">$900 million - $950 million</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Net product revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">$725 million - $775 million</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Cost of goods sold</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">4% - 5% of net product revenues</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Research and development expenses </font><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)(2)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">$500 million - $550 million</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Selling, general and administrative expenses </font><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)(3)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">$250 million - $270 million</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Effective tax rate </font><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">17% - 19%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Cash and investments </font><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(4)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">$1.5 billion - $1.6 billion</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">Guidance updated on August 6, 2020 from previously provided guidance on May 5, 2020.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">Includes $25 million of non-cash stock-based compensation expense.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">Includes $40 million of non-cash stock-based compensation expense.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">This cash guidance does not include any potential new business development activity, which remains a key priority for Exelixis as it continues to build toward becoming a multi-product oncology company.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;padding-left:48px;text-indent:-24px;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Cabozantinib Highlights</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Cabozantinib Franchise Net Product Revenues and Royalties.</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;Net product revenues generated by the cabozantinib franchise in the U.S. were&#160;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$178.7 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;during the second quarter of 2020, with net product revenues of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$173.6 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;from CABOMETYX&#174; (cabozantinib) and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$5.1 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;from COMETRIQ&#174; (cabozantinib). Based upon cabozantinib-related revenues generated by Exelixis&#8217;&#160;partner Ipsen in the second quarter of 2020, Exelixis earned </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$16.3 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;in royalty revenues.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Positive Top-line Results from Pivotal Phase 3 CheckMate -9ER Trial Evaluating Nivolumab in Combination with Cabozantinib in Previously Untreated Advanced Renal Cell Carcinoma (RCC).</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;In April 2020, Exelixis and </font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis Second Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">4</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">August 6, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">BMS announced that CheckMate -9ER, the phase 3 pivotal trial evaluating nivolumab in combination with cabozantinib compared to sunitinib in previously untreated advanced or metastatic RCC, met its primary endpoint of progression-free survival (PFS) at final analysis, as well as the secondary endpoints of overall survival (OS) at a pre-specified interim analysis, and objective response rate. This preliminary analysis of data showed a favorable safety profile for the combination of a 40 mg dose of cabozantinib with nivolumab.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Cabozantinib Data Presentations at the European Society for Medical Oncology Virtual Congress 2020 (ESMO 2020), including Oral Presentation of CheckMate -9ER in the Meeting&#8217;s Presidential Symposium II. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In September 2020, cabozantinib will be the subject of multiple presentations at ESMO 2020 (September 19-21). Notably, detailed results from CheckMate -9ER will be the subject of an oral presentation during the meeting&#8217;s Presidential Symposium II. In addition, data from two cohorts of COSMIC-021 evaluating cabozantinib in combination with atezolizumab, expansion cohort 1 in first-line advanced clear cell RCC and cohort 10 in non-clear cell RCC, will be presented during ESMO 2020 as an oral and a poster presentation, respectively.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Initiation of Three Phase 3 Pivotal Trials of Cabozantinib in Combination with Atezolizumab in Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC), Castration-Resistant Prostate Cancer (CRPC) and RCC. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In June and July 2020, Exelixis announced the initiation of CONTACT-01, CONTACT-02 and CONTACT-03, three global phase 3 pivotal trials of cabozantinib in combination with atezolizumab in patients with previously treated, metastatic NSCLC, CRPC and RCC, respectively. The CONTACT program is part of a joint clinical research collaboration between Exelixis and F. Hoffmann-La Roche Ltd.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">CONTACT-01 is evaluating the combination of cabozantinib and atezolizumab in patients with metastatic NSCLC who have been previously treated with an immune checkpoint inhibitor (ICI) and platinum-containing chemotherapy. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">CONTACT-02 is evaluating the combination of cabozantinib and atezolizumab in patients with metastatic CRPC who have been previously treated with one novel hormonal therapy.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">CONTACT-03 is evaluating the combination of cabozantinib and atezolizumab in patients with metastatic RCC who progressed during or following treatment with an ICI as the immediate preceding therapy.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Completion of Patient Enrollment for COSMIC-312 Phase 3 Pivotal Trial in Previously Untreated Hepatocellular Carcinoma (HCC).&#160;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Today, Exelixis is announcing the completion of patient enrollment in COSMIC-312, a global phase 3 pivotal trial of cabozantinib in combination with atezolizumab versus sorafenib in previously untreated advanced HCC, providing the patient population for the event-driven analyses of the study&#8217;s endpoints. Separately, patient enrollment remains open in China with a focus on enrolling the necessary patient number to enable local registration, if supported by the clinical data. The co-primary endpoints of the trial are PFS and OS for the combination of cabozantinib and atezolizumab versus sorafenib. Based on current event rates, Exelixis anticipates announcing top-line results in&#160;the first half of&#160;2021.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Announcement of Results from Phase 1b COSMIC-021 Trial of Cabozantinib in Combination with Atezolizumab in Multiple Advanced Solid Tumor Types. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In May 2020, Exelixis announced encouraging results from three expansion cohorts of the phase 1b COSMIC-021 trial evaluating the combination of cabozantinib and atezolizumab in patients with metastatic NSCLC, CRPC and urothelial carcinoma. These data were subsequently presented during the 2020 American Society of Clinical Oncology Virtual Scientific Program.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Completion of Patient Enrollment for EXAMINER Phase 4 Trial of Cabozantinib in Metastatic Medullary Thyroid Cancer. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In July 2020, Exelixis completed patient enrollment in EXAMINER, the phase 4 trial evaluating the safety and efficacy of the 60 mg tablet formulation of cabozantinib compared with the 140 mg capsule formulation, which is marketed as COMETRIQ, for the treatment of patients with progressive, metastatic medullary thyroid cancer. EXAMINER is a post-marketing requirement from the U.S. Food and Drug Administration (FDA) and the </font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis Second Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">5</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">August 6, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">European Commission. The trial was designed to enroll up to 250 patients, and top-line results from the trial are anticipated later this year.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Corporate Updates</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Takeda Pharmaceutical Company Limited (Takeda) Records First Commercial Sale of CABOMETYX in Japan.&#160;&#160;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In March 2020, Takeda, Exelixis&#8217; partner responsible for the clinical development and commercialization of CABOMETYX in Japan, received approval from the Japanese Ministry of Health, Labour and Welfare to manufacture and market CABOMETYX as a treatment for patients with curatively unresectable or metastatic RCC. During the second quarter of 2020, Takeda launched CABOMETYX in Japan, triggering a $31.0 million milestone payment to Exelixis from Takeda upon the first commercial sale of CABOMETYX, of which</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$23.7 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">was recognized as revenue in this quarter.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Exelixis Files Second Complaint in Patent Infringement Lawsuit against MSN Pharmaceuticals, Inc. (MSN).&#160;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In May 2020,&#160;Exelixis&#160;filed a second complaint in the company&#8217;s patent infringement lawsuit against MSN, following receipt of notice from MSN&#160;that it had amended its Abbreviated New Drug Application (ANDA), originally filed with the FDA in&#160;September 2019, to add two previously-unasserted CABOMETYX Orange Book-listed patents:&#160;U.S.&#160;Patent No. 7,579,473, the composition of matter patent, and&#160;U.S.&#160;Patent No. 8,497,284, a method of use patent.&#160;Exelixis is seeking, among other relief, an order that the effective date of any FDA approval of the ANDA would be a date no earlier than the expiration of all of U.S. Patent No. 7,579,473, U.S. Patent No. 8,497,284, and U.S. Patent No. 8,877,776, the latest of which expires on October 8, 2030, and equitable relief enjoining MSN from infringing this patent.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">FDA Approves Tecentriq&#174; (Atezolizumab) Plus COTELLIC&#174; (Cobimetinib) and Zelboraf&#174; (Vemurafenib) for Previously Untreated BRAF V600 Mutation-Positive Advanced Melanoma. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In July 2020, the FDA approved the supplemental Biologics License Application (sBLA) submitted by Genentech, Inc. (a member of the Roche Group) (Genentech), for Tecentriq plus COTELLIC and Zelboraf for the treatment of BRAF V600-mutation positive advanced melanoma in previously untreated patients. The approval is based on positive results from the phase 3 IMspire150 study, which demonstrated that adding Tecentriq to COTELLIC and Zelboraf helped to reduce the risk of disease worsening or death, compared to placebo plus COTELLIC and Zelboraf. This is the second FDA approval for a regimen including COTELLIC, which was discovered by Exelixis and is now being developed by Genentech as part of a worldwide collaboration agreement between the two companies.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis has adopted a 52- or 53-week fiscal year that generally ends on the Friday closest to December 31</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">st</sup></font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. For convenience, references in this press release as of and for the fiscal periods ended July 3, 2020, January 3, 2020 and June 28, 2019 are indicated as being as of and for the periods ended June 30, 2020, December 31, 2019 and June 30, 2019, respectively. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Conference Call and Webcast</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis management will discuss the company&#8217;s financial results for the second quarter of 2020 and provide a general business update during a conference call beginning at 5:30 p.m. EDT / 2:30 p.m. PDT today, Thursday, August 6, 2020.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">To access the webcast link, log onto </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">www.exelixis.com</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;and proceed to the News &amp; Events / Event Calendar page under the Investors &amp; Media heading. Please connect to the company&#8217;s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the </font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis Second Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">6</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">August 6, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">webcast. Alternatively, please call </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">855-793-2457</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(domestic) or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">631-485-4921</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(inte</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">rnational) and provide the conference call passcode 6548897</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">to join by phone.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">A telephone replay will be available until 8:00 p.m. EDT on August 8</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. Access numbers for the telephone re</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">play are: </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">855-859-2056</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(domestic) and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">404-537-3406</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(inte</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">rnational); the passcode is 6548897. A webcast replay will also be archived on </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">www.exelixis.com</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for one year.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">About Exelixis</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Founded in 1994,&#160;Exelixis, Inc.&#160;(Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model system genetics, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. Our discovery efforts have resulted in four approved products, CABOMETYX&#174; </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">(cabozantinib), COMETRIQ</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#174;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;(cabozantinib), COTELLIC</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#174; </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">(cobimetinib) and MINNEBRO</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#174;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(esaxerenone), and we have entered into partnerships with leading pharmaceutical companies to bring these important medicines to patients worldwide. Supported by revenues from our marketed products and collaborations, we are committed to prudently reinvesting in our business to maximize the potential of our pipeline. We are supplementing our existing therapeutic assets with targeted business development activities and internal drug discovery - all to deliver the next generation of&#160;Exelixis&#160;medicines and help patients recover stronger and live longer.&#160;Exelixis&#160;is a member of Standard &amp; Poor&#8217;s (S&amp;P) MidCap 400 index, which measures the performance of profitable mid-sized companies. For more information about&#160;Exelixis, please visit&#160;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">www.exelixis.com</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, follow </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;">@ExelixisInc</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;on Twitter or like </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;">Exelixis, Inc.</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;on Facebook.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Forward-Looking Statements</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">This press release contains forward-looking statements, including, without limitation, statements related to: Exelixis&#8217; plans to present data from CheckMate -9ER and the clear cell RCC and non-clear cell RCC cohorts of COSMIC-021 at ESMO 2020; Exelixis&#8217; regulatory filing plans and launch readiness preparations with respect to the combination of nivolumab and cabozantinib as a treatment for patients with RCC; the potential utility of cabozantinib in additional disease settings; Exelixis&#8217; plans to file up to three new Investigational New Drug applications by the end of 2020; Exelixis&#8217; updated 2020 financial guidance; Exelixis&#8217; anticipated timelines for top-line results from COSMIC-312 and EXAMINER; and Exelixis&#8217; plans to reinvest in its business to maximize the potential of the company&#8217;s pipeline, including through targeted business development activities and internal drug discovery. Any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and are based upon Exelixis&#8217; current plans, assumptions, beliefs, expectations, estimates and projections. Forward-looking statements involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of these risks and uncertainties, which include, without limitation: the continuing COVID-19 pandemic and its impact on Exelixis&#8217; clinical trial, drug discovery and commercial activities; the degree of market acceptance of CABOMETYX and other&#160;Exelixis&#160;products in the indications for which they are approved and in the territories where they are approved, and Exelixis&#8217; and its partners&#8217; ability to obtain or maintain coverage and reimbursement for these products; the effectiveness of CABOMETYX and other&#160;Exelixis&#160;products in comparison to competing products; the level of costs associated with Exelixis&#8217; commercialization, research and development, in-licensing or acquisition of product candidates, and other activities; Exelixis&#8217; ability to maintain and scale adequate sales, marketing, market access and product distribution capabilities for its products or to enter into and maintain agreements with third parties to do so; the availability of data at the referenced times; the potential failure of cabozantinib and other&#160;Exelixis&#160;product candidates, both alone and in combination with other therapies, to demonstrate safety and/or efficacy in clinical testing; uncertainties inherent in the drug discovery and product development process; Exelixis&#8217; dependence on its relationships with </font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis Second Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">7</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">August 6, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">its collaboration partners, including their pursuit of regulatory approvals for partnered compounds in new indications, their adherence to their obligations under relevant collaboration agreements and the level of their investment in the resources necessary to complete clinical trials or successfully commercialize partnered compounds in the territories where they are approved; complexities and the unpredictability of the regulatory review and approval processes in the&#160;U.S.&#160;and elsewhere; Exelixis&#8217; continuing compliance with applicable legal and regulatory requirements; unexpected concerns that may arise as a result of the occurrence of adverse safety events or additional data analyses of clinical trials evaluating cabozantinib, cobimetinib or esaxerenone; Exelixis&#8217; dependence on third-party vendors for the development, manufacture and supply of its products and product candidates; Exelixis&#8217; ability to protect its intellectual property rights; market competition, including the potential for competitors to obtain approval for generic versions of Exelixis&#8217; marketed products; changes in economic and business conditions; and other factors discussed under the caption &#8220;Risk Factors&#8221; in Exelixis&#8217; Quarterly Report on Form 10-Q filed with the&#160;Securities and Exchange Commission&#160;(SEC) on&#160;May 5, 2020, and in Exelixis&#8217; future filings with the&#160;SEC, including, without limitation, Exelixis&#8217; Quarterly Report on Form 10-Q expected to be filed with the&#160;SEC&#160;on&#160;August 6, 2020. All forward-looking statements in this press release are based on information available to&#160;Exelixis&#160;as of the date of this press release, and&#160;Exelixis&#160;undertakes no obligation to update or revise any forward-looking statements contained herein, except as required by law.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-top:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;">Exelixis, the Exelixis logo, CABOMETYX, COMETRIQ and COTELLIC are registered U.S. trademarks.</font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;">MINNEBRO is a registered Japanese trademark.</font></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">-see attached financial tables-</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="sF3352001E17C562E9B5074B0CDD45003"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis Second Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">8</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">August 6, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">EXELIXIS, INC.</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(in thousands, except per share amounts)</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(unaudited)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Net product revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">178,730</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">193,675</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">372,610</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">373,256</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">License revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">59,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">37,742</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">80,113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">63,306</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Collaboration services revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">21,515</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">8,858</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">33,671</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">19,200</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Total revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">259,479</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">240,275</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">486,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">455,762</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Operating expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Cost of goods sold</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">9,221</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">7,539</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">18,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">15,040</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">114,933</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">81,932</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">216,810</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">145,221</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">59,791</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">58,815</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">122,731</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">118,953</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Total operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">183,945</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">148,286</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">358,051</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">279,214</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">75,534</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">91,989</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">128,343</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">176,548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">5,162</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">6,975</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">12,382</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">13,062</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">803</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">828</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Income before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">80,696</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">99,767</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">140,731</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">190,438</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Provision for income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">13,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">20,725</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">25,298</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">35,621</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:24px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">66,821</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">79,042</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">115,433</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">154,817</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Net income per share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.51</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Weighted-average common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">307,807</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">302,188</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">306,598</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">301,365</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">318,144</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">314,911</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">316,992</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">314,786</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis Second Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">9</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">August 6, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">EXELIXIS, INC.</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEET DATA</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(in thousands)</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(unaudited)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">June&#160;30, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;text-indent:2px;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">December&#160;31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Cash and investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,540,179</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,388,628</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Working capital</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,251,982</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">868,444</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Total assets</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">2,046,548</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,885,670</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Total stockholders&#8217; equity</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,833,324</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,685,970</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><a name="s487D0880438F586BAB830DA93875515D"></a></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">EXELIXIS, INC.</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME </font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(in thousands, except per share amounts)</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(unaudited)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:40%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">GAAP net income</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">66,821</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">79,042</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">115,433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">154,817</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Adjustments:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Stock-based compensation - research and development expenses </font><font style="font-family:Calibri,sans-serif;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">6,112</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">5,138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">11,198</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">9,444</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Stock-based compensation - selling, general and administrative expenses </font><font style="font-family:Calibri,sans-serif;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">10,042</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">9,941</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">18,938</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">18,164</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Income tax effect of the above adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(3,609</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(3,385</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(6,789</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(6,194</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Non-GAAP net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">79,366</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">90,736</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">138,780</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">176,231</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">GAAP net income per share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.22</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.38</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.51</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Non-GAAP net income per share:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.29</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.56</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Weighted-average common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">307,807</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">302,188</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">306,598</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">301,365</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">318,144</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">314,911</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">316,992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">314,786</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:48px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;"></font><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">____________________</font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">Non-cash stock-based compensation expense used for GAAP reporting in accordance with Accounting Standards Codification Topic 718, </font><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;font-style:italic;">Compensation&#8212;Stock Compensation</font><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">.</font></div></td></tr></table><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>exel-20200806.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.exelixis.com/20200806" xmlns:exel="http://www.exelixis.com/20200806" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20200806_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20200806_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20200806_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20200806_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CoverPage" roleURI="http://www.exelixis.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>exel-20200806_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.exelixis.com/role/CoverPage" xlink:href="exel-20200806.xsd#CoverPage" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.exelixis.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>exel-20200806_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.exelixis.com/role/CoverPage" xlink:href="exel-20200806.xsd#CoverPage" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.exelixis.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>exel-20200806_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4_label_en-US" xlink:label="lab_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="lab_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30_terseLabel_en-US" xlink:label="lab_dei_DocumentType_A5A9798584DD51959D07A6C9A5796186" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30_label_en-US" xlink:label="lab_dei_DocumentType_A5A9798584DD51959D07A6C9A5796186" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_A5A9798584DD51959D07A6C9A5796186" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_A5A9798584DD51959D07A6C9A5796186" xlink:to="lab_dei_DocumentType_A5A9798584DD51959D07A6C9A5796186" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_969805E2DF6D5668805410437BE6E2F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92_label_en-US" xlink:label="lab_dei_AmendmentFlag_969805E2DF6D5668805410437BE6E2F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_969805E2DF6D5668805410437BE6E2F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_969805E2DF6D5668805410437BE6E2F5" xlink:to="lab_dei_AmendmentFlag_969805E2DF6D5668805410437BE6E2F5" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_9252F785ED355757A5D8E441BA3AD51D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_9252F785ED355757A5D8E441BA3AD51D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9252F785ED355757A5D8E441BA3AD51D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_9252F785ED355757A5D8E441BA3AD51D" xlink:to="lab_dei_DocumentPeriodEndDate_9252F785ED355757A5D8E441BA3AD51D" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_BA48F3D12234550F901387A8D2AC92B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502_label_en-US" xlink:label="lab_dei_EntityRegistrantName_BA48F3D12234550F901387A8D2AC92B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_BA48F3D12234550F901387A8D2AC92B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_BA48F3D12234550F901387A8D2AC92B5" xlink:to="lab_dei_EntityRegistrantName_BA48F3D12234550F901387A8D2AC92B5" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_6D965228D3705263AFF87F38FA685214" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_6D965228D3705263AFF87F38FA685214" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_6D965228D3705263AFF87F38FA685214" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_6D965228D3705263AFF87F38FA685214" xlink:to="lab_dei_EntityCentralIndexKey_6D965228D3705263AFF87F38FA685214" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_A217C90668B15692A000D1650AF1A412" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_A217C90668B15692A000D1650AF1A412" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_A217C90668B15692A000D1650AF1A412" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_A217C90668B15692A000D1650AF1A412" xlink:to="lab_dei_EntityEmergingGrowthCompany_A217C90668B15692A000D1650AF1A412" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_20259BA8DC1353968FE312B7D2285C12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2_label_en-US" xlink:label="lab_dei_Security12bTitle_20259BA8DC1353968FE312B7D2285C12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_20259BA8DC1353968FE312B7D2285C12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_20259BA8DC1353968FE312B7D2285C12" xlink:to="lab_dei_Security12bTitle_20259BA8DC1353968FE312B7D2285C12" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_FC8B0C6C7B1056599E0E42ACA806535F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8_label_en-US" xlink:label="lab_dei_TradingSymbol_FC8B0C6C7B1056599E0E42ACA806535F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_FC8B0C6C7B1056599E0E42ACA806535F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_FC8B0C6C7B1056599E0E42ACA806535F" xlink:to="lab_dei_TradingSymbol_FC8B0C6C7B1056599E0E42ACA806535F" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_81E621CA754E5D99ADB9F5094EAFE4B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC_label_en-US" xlink:label="lab_dei_SecurityExchangeName_81E621CA754E5D99ADB9F5094EAFE4B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_81E621CA754E5D99ADB9F5094EAFE4B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_81E621CA754E5D99ADB9F5094EAFE4B2" xlink:to="lab_dei_SecurityExchangeName_81E621CA754E5D99ADB9F5094EAFE4B2" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_494E31B8C11051029A4D68930F592DC7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0_label_en-US" xlink:label="lab_dei_EntityFileNumber_494E31B8C11051029A4D68930F592DC7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_494E31B8C11051029A4D68930F592DC7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_494E31B8C11051029A4D68930F592DC7" xlink:to="lab_dei_EntityFileNumber_494E31B8C11051029A4D68930F592DC7" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_D12E4C44FF7258FFB5CAE8AF50C88150" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_D12E4C44FF7258FFB5CAE8AF50C88150" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_D12E4C44FF7258FFB5CAE8AF50C88150" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_D12E4C44FF7258FFB5CAE8AF50C88150" xlink:to="lab_dei_EntityIncorporationStateCountryCode_D12E4C44FF7258FFB5CAE8AF50C88150" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_05FED7A36A1B5FDC80C30EC2D5C8F9C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_05FED7A36A1B5FDC80C30EC2D5C8F9C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_05FED7A36A1B5FDC80C30EC2D5C8F9C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_05FED7A36A1B5FDC80C30EC2D5C8F9C1" xlink:to="lab_dei_EntityTaxIdentificationNumber_05FED7A36A1B5FDC80C30EC2D5C8F9C1" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_DFA57D8C40F45BDD93A3F778802FCDF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_DFA57D8C40F45BDD93A3F778802FCDF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_DFA57D8C40F45BDD93A3F778802FCDF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_DFA57D8C40F45BDD93A3F778802FCDF3" xlink:to="lab_dei_EntityAddressAddressLine1_DFA57D8C40F45BDD93A3F778802FCDF3" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_7DB805DBE95D5533896A55A8AE98C5C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_7DB805DBE95D5533896A55A8AE98C5C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_7DB805DBE95D5533896A55A8AE98C5C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_7DB805DBE95D5533896A55A8AE98C5C5" xlink:to="lab_dei_EntityAddressCityOrTown_7DB805DBE95D5533896A55A8AE98C5C5" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_A419B87CCBF1502C9DAFB7092FF694ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_A419B87CCBF1502C9DAFB7092FF694ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_A419B87CCBF1502C9DAFB7092FF694ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_A419B87CCBF1502C9DAFB7092FF694ED" xlink:to="lab_dei_EntityAddressStateOrProvince_A419B87CCBF1502C9DAFB7092FF694ED" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_27F4ACC9AE4C566BBC638BD270188067" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_27F4ACC9AE4C566BBC638BD270188067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_27F4ACC9AE4C566BBC638BD270188067" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_27F4ACC9AE4C566BBC638BD270188067" xlink:to="lab_dei_EntityAddressPostalZipCode_27F4ACC9AE4C566BBC638BD270188067" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_6C0E0D8CD04A5270A22C874E66E5D132" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D_label_en-US" xlink:label="lab_dei_CityAreaCode_6C0E0D8CD04A5270A22C874E66E5D132" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_6C0E0D8CD04A5270A22C874E66E5D132" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_6C0E0D8CD04A5270A22C874E66E5D132" xlink:to="lab_dei_CityAreaCode_6C0E0D8CD04A5270A22C874E66E5D132" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_F53409C6EBBF5DEF92AA45BFFCCE80CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_F53409C6EBBF5DEF92AA45BFFCCE80CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_F53409C6EBBF5DEF92AA45BFFCCE80CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_F53409C6EBBF5DEF92AA45BFFCCE80CE" xlink:to="lab_dei_LocalPhoneNumber_F53409C6EBBF5DEF92AA45BFFCCE80CE" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_8A1B4A223D4D56FAB5201FABC2AD45D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0_label_en-US" xlink:label="lab_dei_WrittenCommunications_8A1B4A223D4D56FAB5201FABC2AD45D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_8A1B4A223D4D56FAB5201FABC2AD45D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_8A1B4A223D4D56FAB5201FABC2AD45D7" xlink:to="lab_dei_WrittenCommunications_8A1B4A223D4D56FAB5201FABC2AD45D7" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_EC2244BB8A8451DF8481AD8F81968DA5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1_label_en-US" xlink:label="lab_dei_SolicitingMaterial_EC2244BB8A8451DF8481AD8F81968DA5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_EC2244BB8A8451DF8481AD8F81968DA5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_EC2244BB8A8451DF8481AD8F81968DA5" xlink:to="lab_dei_SolicitingMaterial_EC2244BB8A8451DF8481AD8F81968DA5" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_116B6ADA8C0B5021B215EE70007C62F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_116B6ADA8C0B5021B215EE70007C62F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_116B6ADA8C0B5021B215EE70007C62F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_116B6ADA8C0B5021B215EE70007C62F1" xlink:to="lab_dei_PreCommencementTenderOffer_116B6ADA8C0B5021B215EE70007C62F1" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_D69C5B495BF35FF0BFAAE945CBF6A95D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_D69C5B495BF35FF0BFAAE945CBF6A95D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_D69C5B495BF35FF0BFAAE945CBF6A95D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_D69C5B495BF35FF0BFAAE945CBF6A95D" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_D69C5B495BF35FF0BFAAE945CBF6A95D" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>exel-20200806_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.exelixis.com/role/CoverPage" xlink:href="exel-20200806.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.exelixis.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_A5A9798584DD51959D07A6C9A5796186" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_DocumentType_A5A9798584DD51959D07A6C9A5796186" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_969805E2DF6D5668805410437BE6E2F5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_AmendmentFlag_969805E2DF6D5668805410437BE6E2F5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_9252F785ED355757A5D8E441BA3AD51D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_DocumentPeriodEndDate_9252F785ED355757A5D8E441BA3AD51D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_BA48F3D12234550F901387A8D2AC92B5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityRegistrantName_BA48F3D12234550F901387A8D2AC92B5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_6D965228D3705263AFF87F38FA685214" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityCentralIndexKey_6D965228D3705263AFF87F38FA685214" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_A217C90668B15692A000D1650AF1A412" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityEmergingGrowthCompany_A217C90668B15692A000D1650AF1A412" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_20259BA8DC1353968FE312B7D2285C12" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_Security12bTitle_20259BA8DC1353968FE312B7D2285C12" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_FC8B0C6C7B1056599E0E42ACA806535F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_TradingSymbol_FC8B0C6C7B1056599E0E42ACA806535F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_81E621CA754E5D99ADB9F5094EAFE4B2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_SecurityExchangeName_81E621CA754E5D99ADB9F5094EAFE4B2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_494E31B8C11051029A4D68930F592DC7" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityFileNumber_494E31B8C11051029A4D68930F592DC7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_D12E4C44FF7258FFB5CAE8AF50C88150" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityIncorporationStateCountryCode_D12E4C44FF7258FFB5CAE8AF50C88150" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_05FED7A36A1B5FDC80C30EC2D5C8F9C1" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityTaxIdentificationNumber_05FED7A36A1B5FDC80C30EC2D5C8F9C1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_DFA57D8C40F45BDD93A3F778802FCDF3" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityAddressAddressLine1_DFA57D8C40F45BDD93A3F778802FCDF3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_7DB805DBE95D5533896A55A8AE98C5C5" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityAddressCityOrTown_7DB805DBE95D5533896A55A8AE98C5C5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_A419B87CCBF1502C9DAFB7092FF694ED" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityAddressStateOrProvince_A419B87CCBF1502C9DAFB7092FF694ED" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_27F4ACC9AE4C566BBC638BD270188067" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_EntityAddressPostalZipCode_27F4ACC9AE4C566BBC638BD270188067" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_6C0E0D8CD04A5270A22C874E66E5D132" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_CityAreaCode_6C0E0D8CD04A5270A22C874E66E5D132" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_F53409C6EBBF5DEF92AA45BFFCCE80CE" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_LocalPhoneNumber_F53409C6EBBF5DEF92AA45BFFCCE80CE" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_8A1B4A223D4D56FAB5201FABC2AD45D7" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_WrittenCommunications_8A1B4A223D4D56FAB5201FABC2AD45D7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_EC2244BB8A8451DF8481AD8F81968DA5" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_SolicitingMaterial_EC2244BB8A8451DF8481AD8F81968DA5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_116B6ADA8C0B5021B215EE70007C62F1" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_PreCommencementTenderOffer_116B6ADA8C0B5021B215EE70007C62F1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_D69C5B495BF35FF0BFAAE945CBF6A95D" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5C53F56727BD56389D58AF7BC33EB086" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_D69C5B495BF35FF0BFAAE945CBF6A95D" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>exellogo18q3a18.jpg
<TEXT>
begin 644 exellogo18q3a18.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M                ]M8  0    #3+4A0("
M                                     !%C<')T   !4    #-D97-C
M   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G
M6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q
M (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $
M#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#
M   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A
M8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M             !)S4D="($E%0S8Q.38V+3(N,0
M                                            6%E:(        /-1
M  $    !%LQ865H@                     %A96B        !OH@  ./4
M  .06%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E
M<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%
M0R!H='1P.B\O=W=W+FEE8RYC:
M                          !D97-C         "Y)14,@-C$Y-C8M,BXQ
M($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)
M14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                            9&5S8P         L4F5F97)E;F-E(%9I
M97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E
M9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                             '9I97<      !.D_@ 47RX $,\4  /M
MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                         H\    "<VEG(     !#4E0@8W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$
M P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0
M 0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E
M\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W
M>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'
MR,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]
M_**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*.(L5GN:5LUQC]^K)NW1+:,5Y15DO)!1117K'@A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY2I[]%'7\:^/:*_%,P\3N(\7*[Q#@NT$HI?-+F^]L_I;*/!'@W 045@U4?\
M-4;FW\F^7[HH^I(O^"PWQL2YDD_M70W63 $9TF+;'CTQSS[D_A78>#?^"X'Q
M'TF51K?ASPGK,(Z^3'-:3'_@6]U_\<KXKHKSZ''W$5*7-'&3^;YE]SNCUL5X
M4<'UX<D\NI)?W8\K^^-G^)^K/P:_X+0_#3Q[<0VOB:QU?P5=28'FS+]MLP3Q
MCS(QO'U,8 [D5]7^$O&6D^/]!@U;0]4T_6-,NAF*ZLIUGBD^C*2/\*_GWKNO
M@7^TCXT_9P\3KJGA'7+K2Y&(,]OG?:W8])8C\K_4C([$'FOT3A[QLQM*:IYO
M352/\T5RR7G;X7Z+E]3\AXN^C/EF(IRK</571GTA-N4'Y<WQQ]6Y^A^\5%?,
MO[#O_!2CPW^U>D.AZK'!X=\<*F38E_\ 1]1P,LULS')(P28S\P'0L 2/IJOZ
M&RC.,'F>&CB\#-3@^JZ/LUNFNS/Y!X@X=S'),;++\TI.G4CT>S71IK1I]&KH
M****],\4**** "BBB@ HHHH **** "BBB@ HHHH **** *FM:Q:>'-'NM0O[
MF&SL;&%[BXN)G"1PQJ"S,Q/   ))K\>/^"A_[;UW^UQ\2_LVFR7%OX)T*1DT
MNV8E?M3]&NI%_O-R%!^ZIQP2V?6O^"L'[?'_  LG5[KX8^$;S/A_39MNM7L+
M_+J4Z'B!2.L4;#)/\3@=E!;X;K^8_%;C[Z[4>39?+]U%^_)?:DNB_NQ?WOR2
MO_;G@+X4?V;1CQ'FT/W\U^[B_L1?VGVG);?RQ\VTGPPM<2K'&K222$*JJ-Q8
MGH /4U^TO_!/K]EQ?V6/V>=/TRZA5?$>L8U'67 &Y9F48ASZ1+A?3=O(^]7P
MK_P2%_95/QC^-C>-=5M_,\/>")%EA#KE;J_/,2_]L_\ 6'T(C[-7ZO5]!X+\
M*^SI2SS$+65XT_3[4OF]%Y)]&?(_22X\]M7APQA)>["TZMNLGK"'_;J?,^EW
M'K$****_?#^40HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K\Y?^"IW_!12XO=1U+X7^!;[RK2#=;>(-3@?YIWZ/:1L.BCI(1R
M3E. &W?1'_!3C]K63]F'X#M;Z3<>3XL\6%['364_/:H!^^N![HK*%/9W0\@&
MOQW=VD<LQ+,QR23R37X/XN<<U,*O[$P,K3DKU)+=)[17FUJ_*RZL_JCZ/OA?
M2QTO]9LTAS4XNU*+6DI)ZS:ZJ+TC_>3?V4-HHHK^:S^T HHHH **** "BBB@
M"?3]1N-'U"&[LYYK6ZMI%EAFA<QR1.IR&5AR"#@@CD5^L'_!,O\ ;_7]I?PT
M/"7BFX1?'6CP;A,V%&M0+QYJCIYJ@C>O?[XXW!?R8K:^'GC_ %;X5^.-+\1Z
M'=O8ZMH]PMU;3+_"RGH1W4C((/!!(.0:^QX+XOQ&08Y5X7=.6DX]UW_Q+=/Y
M;-GYWXE>'N#XLRN6%JI1K1NZ<^L9=G_=EM)?-:I'] 5%<#^S/\>-._:5^"FA
M>,--41+J<&+FWW;C:7"G;+$?]U@<$XRNTX&:[ZO[3PN*I8FC'$4'S0DDT^Z:
MNF?YJX[ U\'B:F$Q,7&I3DXR3W33LU\F%%%%=!RA1110 4444 %%%% !1110
M 4444 %?%?\ P54_;Y_X4YX?N/AWX2O,>*]6@QJ=W"_S:1;N,[01TFD4\=U0
M[NK*:]7_ &_/VUK']D#X6M);-;W?C#6E:+2+)SD(>AN)!U\M/3^)L+ZD?C=X
MD\1W_C#Q!>ZMJEW/?:EJ4[W-U<S,6DGD<EF9CW))-?BOBIQ]]0I/*,!+]]->
M^U]B+Z+^])?<M=VFOZ6\!_"C^UJ\>(<VA_L]-_NXO_EY-=7WA%_*4M-DTZ-:
M7A'PIJ'COQ3I^BZ3:R7FIZM<):6L$8RTLCL%4#\2/I6;7WU_P1;_ &5?[:U^
M^^*FL6V;72R^GZ&KCAYR,33C_<4[ >A+OW6OY_X5X?JYSF=+ 4MI.\GVBMW]
MVW=V74_K3CKBRAPWDE;-J^KBK17\TWI&/WZNVT4WT/M[]EG]G_3_ -F3X':'
MX0L?+DDL(O,OKA!_Q^73\RR^N"W"YY"A1VKT2BBO[BP>%I86A##4%:$$DEV2
M5D?Y@YACZ^-Q-3&8J7-4J2<I-]6W=O[PHHHKH.,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHKE?C?X\_X57\&O%?B4;=V@Z1=7Z
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MTL DV[EMX_O22L/[J(&8^RFOW/\ A9\-=*^#GPYT;POHL/V?2]#M4M8%/WF
MZLQ[LS$L3W+$U\>?\$9?V5/^$)\ 7?Q,U>WVZIXF1K725=>8+)6&Z3D<&5UX
M_P!B-2.'-?<E?U1X1<*_V=EO]HUU^]KV:\H?97_;WQ/RY>Q_"?TA.._[7SG^
MQ\+*]#"MIVVE4VD_^W?A79\W1A1117Z\?SV%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0H YK^AO ?FOC>W[O[_?/Y%^E5R6RQ?:_??=^Z+%%%%?T,?R"%%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG_16OB9_X5-]_P#':/\ AM;XR?\ 16OB9_X5-]_\=KS+YO:CYO:BR"[/3?\
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M5-]_\=KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?^%3??_':/^&UOC)_T5KXF?\
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MXI?$:\L[SQ%I\$\$_B2\DBGC:YC5D93(0RD$@@C!!K]YJ_G4_9>_Y.5^'?\
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M5E9205((()!K]UJ_GG_8I_Y/(^$O_8Y:/_Z70U_0Q6-3<TAL%%%%9EA1110
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M66\G^2Z)+HE9):)!1117<>6%%%% !1110 5^<?\ P5H_;Y_MBYO/A3X-OO\
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M5.S/V:HHHK,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV_:@^("^-?%5GN\ ^&;@8AE7Y=:NUPPAP>#$G!D['(3G+$?LJB+$BJJA548
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MKF/F]JZ?X*_\EC\)?]AFS_\ 1Z4@/Z/J***Y3H"BBB@ HHHH **** "BBB@
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MYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:OVC_X(E_
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MF]J/F]J #YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J
M#YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]JU? W@;6/B9XOT
M[P_X?TZZU;6=6F6WM+2W3=),Y[#VZDDX  ). ":0'UG_ ,$0O@'-\4_VPHO$
MTT!?2? -H]_(Y'R&YE5H8$_WN9)!_P!<?P/[.UX;_P $^?V.K3]BW]GNQ\.L
MT-UXAU!OM^N7<?W9KIE V(3SY<:@(O3."V 6(KW*N>4KLVBK(****DH****
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M1110 4444 %4M?U^Q\*:'>:GJ5U;V.GV$+3W%S.X2."-1EF8G@  5=K\O_\
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M-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4
M'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U
M'S>U'S>U !\WM4NG:C<:3J$-W:3S6MU:R+-#-"Y22)U.596'(8$ @CD$9J+Y
MO:K.AZ)>>)M:M-.T^UFO+^_F2WM[>%"\D\CD*J*!R220 /4T ?K1_P $D/\
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M"OA'2X=)T?3Q\L:?,\SG[TDCGEY&QRQY.!V  ZRBBLS0**** "BBB@ HHHH
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MQ#:V=G$T\\\SA(X8U!+,S'@* "23P *_$/\ X*@_M]W7[9OQ:-CH\\T/P_\
M#4K1Z3!RGVZ3D->2*>=S<A ?NIQ@%GS48W9,I6/(OVJ/VEO$'[6GQHU3QEXB
ME_?7C>7:6JMF+3K92?+@3V4$Y.!N8LQY8UYW\WM1\WM1\WM708A\WM1\WM1\
MWM1\WM3 /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;VK]%?\ @B]_P3M_
MX3'5+7XP>-+'_B4Z?+GPU8SIQ>3*>;Q@?^6:'B/^\X+<!%W> _\ !,O]@J\_
M;3^, EU*.:W\!^&Y$FUFZ&5^TGJEI&>N]\'<1]Q,G@E ?W#T/1+/PSHMIING
MVL-E86$*6]M;PH$C@C0!510.     /2LJDNAI&/5ENBBBL30**** "BBB@ H
MHHH *_-__@XA_P"1,^%O_7YJ/_H%O7Z05^;_ /P<0_\ (F?"W_K\U'_T"WJH
M[DRV/RZ^;VH^;VH^;VH^;VKI,0^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J
M#YO:CYO:CYO:OT"_X(5?L_>!_CJ?BE_PF7A70O$W]E_V3]C_ +1M$N/LWF?;
M=^S<#C=L3..NT>E*3LKC2N?G[\WM1\WM7] O_#O[X(_]$K\"_P#@HB_PH_X=
M_?!'_HE?@7_P41?X5G[5%^S9_/U\WM1\WM7] O\ P[^^"/\ T2OP+_X*(O\
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M_P#T>E<Q\WM73_!7_DL?A+_L,V?_ */2D!_1]1117*= 4444 %%%% !1110
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M1YG5A[P&OR>^;VK:G'2YE-ZV#YO:CYO:CYO:CYO:M2 ^;VH^;VH^;VH^;VH
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M* "BBB@#^?G_ (*!_P#)[GQ5_P"QFOO_ $:U>0?-[5Z__P % _\ D]SXJ_\
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MH#GCY4\Z3\I)I!_P&OE+YO:NW_:;\7GX@?M'>/M<,GF#5O$5_=J<Y&U[B1E
MZ\ $ >PKB/F]JZH[&#W#YO:CYO:CYO:CYO:F(/F]J/F]J/F]J/F]J #YO:CY
MO:CYO:CYO:@#[)_X(Y?L.V?[3WQANO%7B:U6Z\'^"7CD-M(,QZE>M\T43#^*
M- "[CO\ (I!5FK]G%4(N!P!T'I7S7_P2/^%T/PO_ &#/!02-4NO$,<NMW;C_
M ):O/(2A/TA6%?\ @-?2E<TI79M%604445)04444 %%%% !1110 4444 >7_
M +1_[&_PY_:NT7[+XU\-V>H7,:;+?48AY-_:?[DR_-@'G:<H3U4U^<?[2_\
MP09\;>";JXOOAGJUKXQTO.Z/3[V1+/4HA_=W-B&3'][,9.>%K];**I2:)<4S
M^=OQ]^R=\3OA;/(GB#X?^,-+$6<RRZ5-Y)P"21(%*,, \@D<&N5L_A[K^HW*
MPV^AZQ/,^=J1V4C,V!DX &>F:_I.HJO:$^S/P.^$G_!-/XW_ !FO(TTWX>Z]
MI]NYYN]8A_LV!%_O9FVEA_N!C[&OOC]C_P#X(8^%_A=?6NN?%#4+;QIJT+"1
M-)MT9=*A8?WRV'N.QPP1>Q5A7WS12=1LI12([.TATZTBM[>*.&WA01QQQJ%2
M-0,!0!P !P *DHHJ"@HHHH **** "BBB@#G?B3\)?"_QCT Z7XK\/Z/XBT_D
MB#4;1+A4)_B7<#M;W&"*^<_&_P#P19^ /B^XDFM_#>J:#))DM_9NK3*N3W"R
MF11]  /:OJZBG=H#X[\/?\$-O@/HMV)+FS\5:LH.?*N]7*H>O'[I8V_7M7OG
MP5_9!^&/[.Q#^#/!.@Z'=!=GVM(/-O"OH9Y"TI'L6KTBBCF8K(****0PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M^?G_ (*!_P#)[GQ5_P"QFOO_ $:U>0?-[5Z__P % _\ D]SXJ_\ 8S7W_HUJ
M\@^;VKJCL<X?-[4?-[4?-[4?-[4P#YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;
MVH _H%_X)^_\F0_"K_L6+'_T2M>P5X__ ,$_?^3(?A5_V+%C_P"B5KV"N0WC
ML%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\G_ &S/V2M!_;*^"5]X3UC;;W8_TC2M1";I--N@#MD'
MJIY5E_B5CT."/6** /YO_C!\(]>^!'Q*U?PGXFLFT_6M%G,%Q$>5/=70_P 2
M,I#*W0J0>]<U\WM7[3_\%8?^">Z?M:?#3_A)_#-JO_"PO"\#&W5!SK%L,LUJ
M?]L'+1G^\2O ?*_BU<6\EI<20S1O#-$Q1T<;61AP01V(KIC*Z,91L-^;VH^;
MVH^;VH^;VJB0^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:OU9_X(P_\
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MK_R6/PE_V&;/_P!'I7,?-[5T_P %?^2Q^$O^PS9_^CTI ?T?4445RG0%%%%
M!1110 4444 ?S.W5S)>W4DTK&269B[L>K,3DDTSYO:G7%O):7$D4BM')&Q1U
M88*D<$&F_-[5UG.'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-
M[4?-[4 ?O[_P3LU^U\2_L-?"VXLS&88_#UM:MY9./,A7R9.YYWQMGWSTZ#VB
MOR]_X(=?MSZ;X6@F^#OBB]CLUO+IKOPU<SOMC:60CS+/)X4LWSH/XF:09W%
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ML%%%%24%%%% !1110 4444 %%%% !1110 5^;_\ P<0_\B9\+?\ K\U'_P!
MMZ_2"OS?_P"#B'_D3/A;_P!?FH_^@6]5'<F6Q^77S>U'S>U'S>U'S>U=)B'S
M>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[5^F?_!NGT^,7_<%_]R%?F9\W
MM7Z9_P#!NGT^,7_<%_\ <A45/A*CN?IE1117.;!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '"_M0?\FT_$3_L6=2_
M])9:_G4^;VK^BO\ :@_Y-I^(G_8LZE_Z2RU_.I\WM6U(SJ!\WM1\WM1\WM1\
MWM6IF'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0!Z;^Q3_R>1\)?^QRT?_TN
MAK^ABOYY_P!BG_D\CX2_]CEH_P#Z70U_0Q6%3<UI[!1116984444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7S+_P6*_Y1Q_$;_N&_P#ISM*^FJ^9
M?^"Q7_*./XC?]PW_ -.=I51W0'X:?-[4?-[4?-[4?-[5TG.'S>U'S>U'S>U'
MS>U !\WM1\WM1\WM1\WM0 ?-[5T_P5_Y+'X2_P"PS9_^CTKF/F]JZ?X*_P#)
M8_"7_89L_P#T>E(#^CZBBBN4Z HHHH **** "BBB@ HHHH **** .-^/?P6T
MC]H;X2:UX1UI?]"UB QK*JY>UE'S1S)_M(P##L<8/!(K\.?B]\*]8^"/Q+UC
MPKKT'V?5-%N&MY@/NR#JLBGNCJ593W# U^_%?$O_  6%_9!_X61\/E^)6AVN
M[6_"\.S54C3YKRQSG><#EH22<_W"V?N@5^/^+?"/]HX'^TL,OWM%:]Y0W:]8
M_$O*ZW:/Z&^C_P"(7]C9K_8N,E;#XEJU]HU-D_2>D7Y\KT29^7M%%%?RF?WD
M%%%% !1110 4444 ?9G_  2%_; _X5'\3&^'VNW>SP[XNF'V%Y&^2ROSA5')
MP%E&$/\ M"/IEC7ZH5_/-#,UO*LD;-')&0RLIP5(Y!![8K]D_P#@G!^UTO[5
M?P*A_M&X5_%WAH)9:PI/S3\'RKG'I(%.>GSJ_ &*_I#P;XO]I3>18J7O1NZ;
M?5;N/RW7E?HD?QM]([P]]C57%.!C[L[1K)=);1G_ -O?#+SY7O)GT-1117[X
M?R@%%%% !7R__P %*/V[(?V6/ 7]AZ#<(_CO7H3]D PW]F0G(-RXZ9X(13U8
M$\A2#Z5^V!^U;HO[(WPDN?$&I;;K4KC-OI.G!MKW]QC@>R+P7;L.F25!_%GX
MH_$[6OC)X^U3Q-XBO9-0UC5IC-<3-P/0*HZ*BC"JHX 4 =*_(?%#CU930_L[
M R_VB:U:^Q%]?\3^SV6O:_\ 0?@?X4O/\6LXS.'^R4GHG_R\FNGG"/VN[]W7
MWK8M[>S:E>37%Q-+<7%P[22RR,6>1B<EF)Y)))))Y)-0T45_*3;;NS^]4DE9
M!1112 **** "O7?V(_V9KC]JK]H#2?#FR3^QX6^VZQ,F1Y-HA!<9'1G)"*>S
M.#T!KR*OV _X)9_LJ_\ #.O[/L.J:E;>7XH\9!-0O=X^>V@Q^X@]L*Q=@>0T
MC _=%?>>'?"SSO-HTJB_=4_>GZ+:/_;ST]+OH?EGB_QTN&,@G7HNU>K[E/NF
MUK+_ +<6O;FY4]SZ4TS3;?1=.M[.TACMK6TB6&"&-0J1(H 55 Z    >@JQ1
M17]GQBDK(_S;E)R=WN%%%%,04444 %%%% !1110 4444 %?,O_!8K_E''\1O
M^X;_ .G.TKZ:KYE_X+%?\HX_B-_W#?\ TYVE5'= ?AI\WM1\WM1\WM1\WM72
M<X?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM73_!7_DL?A+_ +#-G_Z/
M2N8^;VKI_@K_ ,EC\)?]AFS_ /1Z4@/Z/J***Y3H"BBB@ HHHH **** /YR?
MVAO"K>!?C]XXT1E\MM'\07]D5';R[B1/4^GJ?QKD/F]J^F/^"O7PR?X:?M[^
M,CY?EVOB P:U;'&-XFB7S#_W^64>^*^9_F]JZH['.P^;VH^;VH^;VH^;VI@'
MS>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 L4K02JZ,R.C!E93AE(Z$'UK]#O
MV&O^"X6H> [*S\,?%Z*\US3(ML,'B*W'F7UNO0?:(_\ ELHX^=?WF <B0FOS
MP^;VH^;VI2BGN-.Q_1Y\)?C;X1^._AE=8\'>(M)\1:<<!I;*<2&$D9"R+]Z-
ML?PN P]*ZFOYL_ /Q(\0?"KQ'#K'AG6M4T'5(?N75A<O;R@9!QN4@E3@9!X/
M<&OL+X$?\%V/BM\.%@M?%UEH_CS3X\*TDR?8;XJ.,"6(;#QW:)B3WZYQ=-]#
M1374_8JBOC/X-_\ !<KX,_$18X?$#:[X'O6 #?;[0W-KN/998-YQ[NB"OJ#X
M:_';P5\9K3SO"?BSP[XB3;N(T_4(KAT'^TJL64^Q -0XM;EW1UE%%%( HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX9_\#9_\*/\ B(7\9?\ 1._#/_@;/_A1R,.9'ZM45^4O_$0OXR_Z)WX9_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% !1110 4444 %?,O_!8K_E''\1O^X;_ .G.TKZ:KYE_X+%?\HX_B-_W#?\
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M_K,_@,**** "BBB@ HHHH **** "BBB@ HHHH *^9?\ @L5_RCC^(W_<-_\
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M?L1?#W0[J-H;Y]-_M&Y1AATDNI'N2K?[2B4+[;<5E4V+I[GN-%%%8FH4444
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M]M3P=^VG\/?[9\,W#6^H6>U-4TBX8?:M-D.<!AT9&P=LB\, >C!E'K]?SD?
MOXZ>)OV<?B9IWBSPGJ,FFZQIK<'[T=Q&?O12KT>-@,%3[$8(!'[G_L.?MH^'
M_P!M?X/PZ_I?EV6M6.V#6M*+[I-/G(SQW:-\$H_<9!PRL!C.%C:,KGM%%%%9
ME!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(:?:W5JTGA'P[)'J.O2L/W;Q*V4M\_WIF7;CKM#L/NU^[JJ$7 X Z#TKS?\
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M% !1110 5^;_ /P<0_\ (F?"W_K\U'_T"WK](*_-_P#X.(?^1,^%O_7YJ/\
MZ!;U4=R9;'Y=?-[4?-[4?-[4?-[5TF(?-[4?-[4?-[4?-[4 'S>U'S>U'S>U
M'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\W
MM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\W
MM1\WM0 ?-[4?-[4?-[4?-[4 'S>U7?#'AG4/&GB.QTC2;.?4-3U*=+:UMH5W
M23RN0JJH]22*L^!? 6M?$[Q59Z'X=TN^UK5]0<1V]I9PF660^P'8=23P!R<
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MVH^;VH^;VH /F]JZ?X*_\EC\)?\ 89L__1Z5S'S>U=/\%?\ DL?A+_L,V?\
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M_NRC_B'3_P"JQ?\ EJ?_ '97Z944<\@Y4?F;_P 0Z?\ U6+_ ,M3_P"[*/\
MB'3_ .JQ?^6I_P#=E?IE11SR#E1^9O\ Q#I_]5B_\M3_ .[*/^(=/_JL7_EJ
M?_=E?IE11SR#E1^9O_$.G_U6+_RU/_NRGVG_  ;K1)<+Y_Q>DDB_B6/PN$8_
M0F[./R-?I?11SR#E1\;?!7_@AW\&?AA?0WFN+KGCB[C8,(]4N!%:*P.0?*A"
M[AZAV=3Z5]=>&?"^F^"]!M=*T?3[+2=+L4\NWM+.!8((%Z[510 HZ]!WJ_12
M<F]RK6"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7YY_\
M%G/^"B/_  K[1;KX0^"[[;KFJ0A?$5[ _P UA;N,_95(/$DBGYO[J-CJ_P O
MO?\ P4J_;PLOV*?@ZS6,EO<>./$"/#HEHX#"(CAKJ1?[D>1@'[S$#IN(_#;7
M]?OO%6N7FJ:E=7%]J.HSO<W5S.YDEN)78L[LQY+%B22>I-:4XWU9$I="I\WM
M1\WM1\WM1\WM6YD'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-
M[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 ?
M1_\ P38_;NOOV*?C&KWLEQ<^"/$#I!K=FN6\H9PMU&O_ #TCR>!]Y<KUVD?N
M5X>U^Q\6:#8ZIIEU;WVFZE EU:W,#AX[B)U#(ZD<%2I!!]#7\TWS>U?H3_P1
MB_X*'_\ "NM;M?A%XROMN@ZI/M\.WDS?+I]R[9-LQ[1RL<K_ '9&QT?*Y5(]
M32,NC/U<HHHK$T"BBB@ HHHH **** "BBB@ HHHH **** "OS?\ ^#B'_D3/
MA;_U^:C_ .@6]?I!7YO_ /!Q#_R)GPM_Z_-1_P#0+>JCN3+8_+KYO:CYO:CY
MO:CYO:NDQ#YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J^F?^"=/_  3I
M_P"&_?\ A,?^*R_X1/\ X1/[%_S"?M_VK[1]H_Z;1;-OD?[6=_;'/S-\WM7Z
M9_\ !NGT^,7_ '!?_<A42=D5'</^(=/_ *K%_P"6I_\ =E'_ !#I_P#58O\
MRU/_ +LK],J*QYY&G*C\S?\ B'3_ .JQ?^6I_P#=E'_$.G_U6+_RU/\ [LK]
M,J*.>0<J/S-_XAT_^JQ?^6I_]V4?\0Z?_58O_+4_^[*_3*BCGD'*C\S?^(=/
M_JL7_EJ?_=E'_$.G_P!5B_\ +4_^[*_3*BCGD'*C\S?^(=/_ *K%_P"6I_\
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MK^ABL*FYK3V"BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%1116)H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG_Z/2N8^;VKI_@K_ ,EC\)?]AFS_ /1Z4@/Z/J***Y3H"BBB@ HHHH ****
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M_L6+'_T2M>P5X_\ \$_?^3(?A5_V+%C_ .B5KV"N0WCL%%%% PHHHH ****
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MS>U?IG_P;I]/C%_W!?\ W(5%3X2H[GZ94445SFP4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PO[4'_)M/Q$_[%G4O
M_266OYU/F]J_HK_:@_Y-I^(G_8LZE_Z2RU_.I\WM6U(SJ!\WM1\WM1\WM1\W
MM6IF'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0!Z;^Q3_P GD?"7_L<M'_\
M2Z&OZ&*_GG_8I_Y/(^$O_8Y:/_Z70U_0Q6%3<UI[!1116984444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7S+_P6*_Y1Q_$;_N&_^G.TKZ:KYE_X
M+%?\HX_B-_W#?_3G:54=T!^&GS>U'S>U'S>U'S>U=)SA\WM1\WM1\WM1\WM0
M ?-[4?-[4?-[4?-[4 'S>U=/\%?^2Q^$O^PS9_\ H]*YCYO:NG^"O_)8_"7_
M &&;/_T>E(#^CZBBBN4Z HHHH **** "BBB@ HHHH ***K:IJ=MHFF7%[>3P
MVMG9Q-//-*P6.%%&YF8G@  $DGTI2DDKO8J,7)\L=SYI_P""J'[57_#/'[/\
MND:7<F+Q/XT$EA:%&Q):V^,3S@]00K!%/!#2 C[IK\@J]<_;9_:7N/VJOV@=
M7\2;I5TB(_8M'@?@PVB$[,CLSDEV'9G(Z 5Y'7\7>(?%+SO-I5:;_=0]V'HM
MY?\ ;SU]++H?Z2>$/ JX8X?IT*RM7J^_4[\S6D?^W%IVOS-;A1117PI^I!11
M10 445]#?\$]?V(;S]KKXF>=J"3V_@G0Y%?5;I<J;ENJVL;?WV_B(^ZN3G)4
M'T<IRO$YEBX8+"1YIS=DOU?9+=OHCR,^SW!9-@*F99A/EI4U=O\ ))=6WHEU
M;L>N?\$H?V!_^%E:Q;?$WQ?9AO#NG2DZ+93)E=2G0X,S C!BC8$ ?Q.#V4AO
MTZJGH>BV?AG1;33M/M8+*QL(4M[:WA0)'!&@"JBJ. H   ]!5RO[3X1X7PV0
MX".#H:RWG+K*7?T6R71>=V_\UO$#CK&\59K+,,5I!:4X7TA'HO-O>3ZOR22*
M***^H/APHHHH **** "OS<_X++?L@?V#K,7Q8T&UQ9Z@R6NOQQI@0S\+%<$#
ML_",>/F"=2YK](ZQ_'?@?2_B7X-U3P_K5JEYI6L6SVEU"W\<;C!P>Q'4$<@@
M$<BOF>+N&Z6>99/ U-);Q?\ +);/TZ/R;/MO#WC3$<+YW2S.E=Q^&<?YH/XE
MZ]8_WDNA_/W17HG[4G[/.J?LO?&O5_".I;Y5LW\VQNBNT7MJQ/E2CZ@8(&<,
MK#/%>=U_$.,PE7"UYX:O'EG%M-/HUHS_ $VR_'X?'8:GC,+)2IU$I1:V::NF
M%%%%<YV!1110 4444 :_@3QQJGPT\9Z7X@T6Z:SU71[E+NUF7^!T.1D=P>A!
MX()!R":_<']EK]H72_VH/@GH_B[3=D;7B>5?6H;<;*Z4#S8C]"<@GJK*>]?A
M/7U!_P $M_VOO^&;_C8NAZQ=>7X1\82):W9=ODLKC.V*X]AD[7/ VMDYV"OU
M+PLXP_LC,OJN(E:C6LGVC+[,OT?D[O8_#?'3P]_UAR;Z]A(WQ.'3E&V\H;RA
MYO[4?--+XF?KY1117]='^?(4444 %%%% !1110 4444 %?,O_!8K_E''\1O^
MX;_Z<[2OIJOF7_@L5_RCC^(W_<-_].=I51W0'X:?-[4?-[4?-[4?-[5TG.'S
M>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[5T_P5_Y+'X2_[#-G_P"CTKF/
MF]JZ?X*_\EC\)?\ 89L__1Z4@/Z/J***Y3H"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\B?^"_'PLMO"O[
M2_AOQ1;1I&WBS1O+NL=99[9]F\_]LGA7Z1U^NU?EE_P<.^*8;OXB?#'1%9?M
M&GZ=?7SK@9"SRPHI]>3;M^1]ZNGN3+8_.?YO:CYO:CYO:CYO:N@Q#YO:CYO:
MCYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J_0#_@WOT]I/V@O'5UN79#X>2(CN2]
MS&1_Z ?S%?G_ /-[5^D/_!N[X?\ /\5?%/5MO_'K::=: G//F/<.0!T/^J'N
M,CU-1/X2H[GZB4445SFP4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?S\_P#!0/\ Y/<^
M*O\ V,U]_P"C6KR#YO:O7_\ @H'_ ,GN?%7_ +&:^_\ 1K5Y!\WM75'8YP^;
MVH^;VH^;VH^;VI@'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0!_0+_P3]_Y,
MA^%7_8L6/_HE:]@KQ_\ X)^_\F0_"K_L6+'_ -$K7L%<AO'8****!A1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M7/\ Q4^*&A_!;X>ZMXI\27T>G:+HMNUQ=3OV4=%4=69B0JJ.22 .M 'G?[<7
M[8NB?L6?!*[\2:AY5WJ]SFVT732V&U"Y(X!QR(T^\[=AP/F90?P;^)_Q,UOX
MR?$#5O%'B.^EU+6]<N&N;NXDZNQX  Z*J@!54<*H &  *]$_;@_;$US]M+XW
M7GB;4O-M=)M\VVBZ:6RNGVH.0#V,C?>=N[<?=50/'OF]JZ(1LC&4KA\WM1\W
MM1\WM1\WM5DA\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U?<
MG_!'G_@GA_PT#XSC^(WC"Q\SP3X>N/\ 0+6=/W>M7B'N#]Z&,\MV9@%Y <4G
M*RN"U/HC_@C7_P $\/\ A3OAB#XJ>,;#9XJURW_XDMI.GSZ3:..96!^[-*I^
MJH<<%V4??-%%<S=W<Z$K!1112 *\P_:[_98T#]L#X*:EX/UU5A:;]_I]\$#2
M:;=*#LF3\R&&1N5F&1G->GT4 ?SB_&_X+^(/V>OBEK'@_P 469L]8T68Q2J.
M4E4\I(A_B1U(93W!'TKE/F]J_;?_ (*H?\$_8?VP_A;_ &UH%O"OQ"\,PLVG
MM@*=4@&6:T=O?)9"> Y(X#L1^)E[93:;>36]Q#+;W%N[1RQ2(5>-@<%2#R""
M""#R"*Z(RN8RC8C^;VH^;VH^;VH^;VJR0^;VH^;VH^;VH^;VH /F]J/F]J/F
M]J/F]J #YO:OU)_X(O?\%$3XGT^S^#OC2^SJ%E&5\,WT\G-S$HS]C8G^)!GR
M_51MXVJ#^6WS>U3Z1J]UX?U:UO[&YGL[VQF2XM[B"0QRP2(0RNK#E6! ((Y!
MI2C=6&G8_I>HKYC_ ."8W[?-K^VC\(_LVK2P0^/?#<:1:Q;J @O%Z+=QK_=?
M^(#A7R, %<_3E<NQN%%%% !1110 4444 %%%% !7YO\ _!Q#_P B9\+?^OS4
M?_0+>OT@K\W_ /@XA_Y$SX6_]?FH_P#H%O51W)EL?EU\WM1\WM1\WM1\WM72
M8A\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U?IG_ ,&Z?3XQ?]P7_P!R
M%?F9\WM7Z9_\&Z?3XQ?]P7_W(5%3X2H[GZ94445SFP4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PO[4'_ ";3\1/^
MQ9U+_P!)9:_G4^;VK^BO]J#_ )-I^(G_ &+.I?\ I++7\ZGS>U;4C.H'S>U'
MS>U'S>U'S>U:F8?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U 'IO[%/\ R>1\
M)?\ L<M'_P#2Z&OZ&*_GG_8I_P"3R/A+_P!CEH__ *70U_0Q6%3<UI[!1116
M984444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S+_P %BO\ E''\
M1O\ N&_^G.TKZ:KYE_X+%?\ *./XC?\ <-_].=I51W0'X:?-[4?-[4?-[4?-
M[5TG.'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[5T_P5_P"2Q^$O^PS9
M_P#H]*YCYO:NG^"O_)8_"7_89L__ $>E(#^CZBBBN4Z HHHH **** "BBB@
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MBFNZQ(S,P55&22> * &WEY#IUI+<7$L<-O"ADDDD8*D:@9))/  '.37X&?\
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MT>WT^ZEM+&S:!Y(T"L4+72L5R.,J#["N\_XB /@W_P!"S\3/_!=8_P#R77Y
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M>S0<[/U__P"(@#X-_P#0L_$S_P %UC_\ET?\1 'P;_Z%GXF?^"ZQ_P#DNOR
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M0>"#51E9W$U<_F@^;VH^;VKZQ_X*I?\ !/N;]C[XH#7/#]O*_P /?$\[&P8
ML-+G.6:T<^F,F,GED!')1B?D[YO:NB+N8/0/F]J/F]J/F]J/F]J8!\WM1\WM
M1\WM1\WM0 ?-[4?-[4?-[4?-[4 =K^SQ\??$/[,GQ=T?QEX9N/(U+29<M&V?
M)O(CQ)!(.Z.N0>XX(PP!'[W?LO\ [2?A[]K#X-Z7XR\.2_Z/?+LN;5V!FT^X
M4#S()/\ :4GKT8%6'!%?SN?-[5]#_P#!.#]NK4/V)_C/'<7+3W7@O7F2WUVQ
M3DA <+<QC_GI'DG'\2EEXR&7.<;JY496/W>HJAX8\3Z?XT\.6.KZ3>0:AI>I
MP)=6MS VZ.>)P&5E/H00:OU@;!1110 4444 %%%% !7YO_\ !Q#_ ,B9\+?^
MOS4?_0+>OT@K\W_^#B'_ )$SX6_]?FH_^@6]5'<F6Q^77S>U'S>U'S>U'S>U
M=)B'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[5]?_P#!*/\ X* ^#?V%
MO^$]_P"$MTWQ-J/_  E/]G_9/[(MX)O+^S_:M^_S9H\9\],8SG#9Q@9^0/F]
MJ/F]J35]!IV/U_\ ^(@#X-_]"S\3/_!=8_\ R71_Q$ ?!O\ Z%GXF?\ @NL?
M_DNOR ^;VH^;VJ/9HKG9^O\ _P 1 'P;_P"A9^)G_@NL?_DNC_B( ^#?_0L_
M$S_P76/_ ,EU^0'S>U'S>U'LT'.S]?\ _B( ^#?_ $+/Q,_\%UC_ /)='_$0
M!\&_^A9^)G_@NL?_ )+K\@/F]J/F]J/9H.=GZ_\ _$0!\&_^A9^)G_@NL?\
MY+H_XB /@W_T+/Q,_P#!=8__ "77Y ?-[4?-[4>S0<[/U_\ ^(@#X-_]"S\3
M/_!=8_\ R71_Q$ ?!O\ Z%GXF?\ @NL?_DNOR ^;VH^;VH]F@YV?K_\ \1 '
MP;_Z%GXF?^"ZQ_\ DNC_ (B /@W_ -"S\3/_  76/_R77Y ?-[4?-[4>S0<[
M/U__ .(@#X-_]"S\3/\ P76/_P ET?\ $0!\&_\ H6?B9_X+K'_Y+K\@/F]J
M/F]J/9H.=GZ__P#$0!\&_P#H6?B9_P""ZQ_^2Z/^(@#X-_\ 0L_$S_P76/\
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M<G1K9N?*'I*W!<]1]WLQ;QS_ ()+_L#?VM<6?Q6\8V2M:PGS/#EC.F?.<?\
M+XZG^%?^68/4_/QM0G]&J_I#PFX!]E&.>9A'WG_#B^B?VWYO[/9:]5;^-?'[
MQ6^L3GPOE$_<B[5I+[37_+M/LG\?=^[LG<HHHK]\/Y1"BBB@ HHHH **** "
MBBB@ HHHH *X/]I/X#:3^TK\&M:\(:LJK'J46;:XVY:SN%YBF7W5L9 ZJ67H
M37>45SXK"TL31EAZ\>:,DTT^J>C1U8''5\'B(8O#2<:D&I1:W33NG\F?S_\
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MIMW&.6:'?[_>Z^O.9]FQ^T1^Z-%?BG9?\%O?CY:VRI)K'AZY89_>2:-$&/\
MWS@?I27_ /P6[^/EY!MCUGP_:MG.^+1H2WT^;</TH]FQ\Z/VMJ#4M2M]'L);
MJ\N(;6U@4O+-,XCCC4=RQX ^M?A1XL_X*O?M!>,XVCN/B/J5K&V<+86=K9%
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MSI&AEUY%NC9N)1[/(J(#U'DOV:OT:KGJ/6QM%:!1114%!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!_/S_P4#_Y/<^*O_8S7W_HUJ\@^;VKU_P#X*!_\GN?%7_L9K[_T
M:U>0?-[5U1V.</F]J/F]J/F]J/F]J8!\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4
M?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>
MU'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>
MU'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U?H7_P &]'_)9?B)
M_P!@6W_]'FOST^;VK]#_ /@WGM)'^+7Q&G"GR8](M8V;T9IF('X[6_*HJ;%1
MW/U6HHHKG-@HHHH **** "OF?_@IE^WM9_L5_"'R]-D@N?'?B-'AT:T;YOLR
M]'NY!_<3/R@_?? Y <KZU^TU^T=X=_94^#>K>,_$DVVST]=D%NC 3:A<-GRX
M(@>KL0?95#,<*I(_!#]H[]H+Q#^U!\7]6\9>)KCS-0U*3Y(D)\FSA'$<,8/1
M%''J3DG)))N$;ZDRE8Y#7-;O/$VM7>HZA=37E_?S/<7%Q,Y>2>1R69V)Y)))
M)/J:K?-[4?-[4?-[5T&(?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\
MWM1\WM1\WM0!)9V<VH7<5O;Q23S3N(XXXU+/(Q. H Y))(&!UK]J_P#@E/\
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MFS_]'I7,?-[5U?P(LY-1^.'@VWA7S)KC7;&.-<@;F-P@ R?>D!_1U1117*=
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MWA?P$\VK_P!HXZ/^SP>B?VY+I_A77N_=[V_GOQQ\5ED&$>3Y9/\ VNJM6O\
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M ,EC\)?]AFS_ /1Z5S'S>U=/\%?^2Q^$O^PS9_\ H]*0']'U%%%<IT!1110
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M=I'96D"_\LXT4*O/<\<D\DDD\FMBBBN<V"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH _GY_X*!_\GN?%7_L9K[_ -&M7D'S>U>O_P#!0/\ Y/<^*O\ V,U]_P"C
M6KR#YO:NJ.QSA\WM1\WM1\WM1\WM3 /F]J/F]J/F]J/F]J #YO:CYO:CYO:C
MYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;V
MH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;VH^;VH^;V
MH^;VH /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;VK]4?^#>OX93:7\,O
MB%XNFC98]9U&VTNW9AC(MHWD<K[$W"C/3*>QK\P?!7@S5/B+XPTS0=%LYM0U
M;6+E+.SMHA\TTKL%4#L.3U/ ')Q7]!7[)7[/MG^RW^SQX8\$69CD;1[4?;)U
M'_'U=.2\TGK@R,V,]%"CL*RJ2TL7#<](HHHK$U"BBB@ JEXC\16/A#0+W5=4
MN[?3]-TV![FZN9W"16\2 LSL3P  "2?:KM?E'_P6>_X*'?\ "QM=NOA'X-OM
MV@Z3/CQ#>0O\NH7*-_Q[ CK'$P!;^](/1 6J,;NPF['@O_!2?]NZ^_;6^,;/
M927%MX(\/N\&B6;97S1G#74B_P#/23 X/W5PO7<3\X?-[4?-[4?-[5T15C /
MF]J/F]J/F]J/F]J8!\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U?57_!
M+3_@G]/^V/\ %7^UM=MYH_A[X9F5]2?E?[3F&&6S1ASR,%R.53C(+*:\@_9*
M_9;\0?M??&G3?!^@+Y7GGSK^^9-T6FVJD>9,XXSC.%7(W,57(SD?O9\"_@EX
M>_9U^%FD>#_"]F+/2-'A$:9P9)W/+RR-_%([99CZGC P!G4E;1%QC<ZBPL(-
M*L8;6UAAM[6WC6*&&) D<2*,*JJ. H   ' %3445@:A1110 4444 %%%% !1
M110 4444 %%%% 'PK_P6*_X)X?\ "^O"$GQ*\(6._P 9^'[?&HVL"9?6K1!U
M 'WIHAG;W9,KR50#\A/F]J_IEK\C?^"R'_!.\?!;Q7-\4?!MCY?A'7KC_B;V
M<*?)I%VY_P!8H'W896/3HKDC@,BC6G+HS.<>I\&?-[4?-[4?-[4?-[5L9A\W
MM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U;/P]^(.L?"GQQI?B3P_?3:;K
M6C7"W5I<Q'YHG7]"#R"#D$$@Y!(K&^;VH^;VI ?OO^P7^VAH_P"VO\$K?7K7
MR;/Q!I^VUUW35;FRN,?>4'GRI,%D//&5R65L>W5_/G^QC^UKKG[&WQNL/%>C
M[KBS;%MJNGE]J:C:D@O&?1AC<C?PL!U&0?WG^$'Q;T'X[?#;1_%GAF^34-%U
MJW%Q;RCAE[,CC^%U8%64\AE([5SRC8VC*YTM%%%24%%%% !7YO\ _!Q#_P B
M9\+?^OS4?_0+>OT@K\W_ /@XA_Y$SX6_]?FH_P#H%O51W)EL?EU\WM1\WM1\
MWM1\WM728A\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U
M !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\W
MM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\W
MM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U 'N__!,GX;3?%#]NSX;V<,32
M)INK)K$S#.(TM,W&2?\ >C4#U+ =Z_>ZOSQ_X(/?LCW'@GP7JWQ8UJU:&\\3
M1?V=HBR+AA9*X:6;'I)(J!>AQ$3R'%?H=7/4=V;1V"BBBH*"BBB@ HHHH X7
M]J#_ )-I^(G_ &+.I?\ I++7\ZGS>U?T5_M0?\FT_$3_ +%G4O\ TEEK^=3Y
MO:MJ1G4#YO:CYO:CYO:CYO:M3,/F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@
M ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;VH^;V
MH^;VH^;VH /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;V
MH /F]J/F]J/F]JZ_X!_!/6OVB_C!H/@S0(3)J6NW0@5MI9;=.LDSX_@1 S'V
M4T@/UD_X(3?#27P9^Q;-K-Q'MD\6Z[<WT+$8+01JENO_ (_#*?QK[2KGOA1\
M--+^#7PTT+PIHL9ATOP_916-L&.6*HH7<Q[LV"Q/<DFNAKF;N[G0M$%%%%(
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M1W0'X:?-[4?-[4?-[4?-[5TG.'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#^?G_@H'_R>Y\5?^QFOO_1K5Y!\WM7Z(_M4_P#!
M&CXO?&;]I'QQXLTBY\'KI?B+6;F_M1<:C*DHCDD++N41$!L'IDUP/_#ASXW?
M\_?@7_P:2_\ QFNA21CRL^+/F]J/F]J^T_\ APY\;O\ G[\"_P#@TE_^,T?\
M.'/C=_S]^!?_  :2_P#QFGS(.5GQ9\WM1\WM7VG_ ,.'/C=_S]^!?_!I+_\
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M/C=_S]^!?_!I+_\ &:/^'#GQN_Y^_ O_ (-)?_C-',@Y6?%GS>U'S>U?:?\
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M<K/BSYO:CYO:OM/_ (<.?&[_ )^_ O\ X-)?_C-'_#ASXW?\_?@7_P &DO\
M\9HYD'*SXL^;VH^;VK[3_P"'#GQN_P"?OP+_ .#27_XS1_PX<^-W_/WX%_\
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M(.5GQ9\WM1\WM7VG_P .'/C=_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\
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M,4 \J]@G;<P5B/DC;'!YQ]:<=P/Y_P#YO:CYO:OM/_APY\;O^?OP+_X-)?\
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M:ZH_LWZ-O GL,-/B?%Q]ZI>%*_2*?O2_[>:Y5ULGTD%%%%?@I_58445]>?\
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M-\-O#%IHOA_2['1=)L4V6]G9P+##$/95 ')R2>I)).:UJ**S*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &3XI\!Z'XXM_)UK1=)UB'&-E[:1W"XY[.".Y_,U
MYKXE_8 ^"?BQV:\^%O@A6<Y9K;2HK5F//),04YY/U_ 5[!11=@?-&L?\$?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX/\ >23TJ27V5WA%_*4M=DFRBBBOVT_F8**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR;U;;U;;[MA1116QSA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?FS_P6B_:J.N>);+X5Z1<'[+I)2_UMD;B2X*YA@/J$5MY'(W.G=:^_
M/C3XWU'X=_"O7-9T?1K_ ,0ZM96K&RTZS@::6ZG/RQKM7G;N(+'LH8]J_+#P
M=_P3-^.7[1/CB\UCQ!I/_"/MK%R]Y>ZEKDZQL[R-N<^4NZ4L<G V@9XR.WY/
MXIXW,:N$CDV54ISG6^)Q3:4%T;V7,][O9.^Y^^>!.6Y/0Q\^),]Q%.G3P^D%
M.23E4:W46[OE6UD_>::U3/GOX8?#+6OC'X]TOPUX=L9-0UC5YA!!"OKW9CT5
M% +,QX502>E?M+^QY^RGH_[(_P (K7P_I^RZU*XVW&KZAMPU]<8Y/J$7[J+V
M'J2Q.-^QS^P?X1_8\T-FT\'6/$UXFR]UJYB"S.O!,<2Y/E1Y .T$DD#<3@8]
MQH\-_#S^Q(/&XZSQ$E;35079/JWU:TZ+2[9XS>+W^LU199E;<<'!WN]'4DMF
MUNHK[*>M_>:O91****_6#\#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>exel8-k20200630earning_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="exel-20200806.xsd" xlink:type="simple"/>
    <context id="D2020Q3FilingDateAug06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000939767</identifier>
        </entity>
        <period>
            <startDate>2020-08-06</startDate>
            <endDate>2020-08-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q3FilingDateAug06"
      id="Fact-401B961AA6985EF7BD15776111A0D56B-wk-Fact-401B961AA6985EF7BD15776111A0D56B">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q3FilingDateAug06"
      id="Fact-58AC1E0692B950C78F28784D061C71CC-wk-Fact-58AC1E0692B950C78F28784D061C71CC">0000939767</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e94-wk-Fact-2C45D20106AA56EF9B5F51454828E618">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e108-wk-Fact-31DC0C278BDB59F681BEB9F3E9C2AB2D">2020-08-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e127-wk-Fact-71D0F50744515EA98AABF283F3F147D6">EXELIXIS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e151-wk-Fact-0D93A4D652155A60860FA91D1C3EE5C3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e156-wk-Fact-910D3B60D22C5E4FA15C58DD78F4D3F9">000-30235</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e161-wk-Fact-4F1AB89ADD5550A5AD633F531CB55010">04-3257395</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e183-wk-Fact-741BB315EDA953958EA7624A26B68686">1851 Harbor Bay Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e189-wk-Fact-856643F9E4655AFCBA48159C71ACD934">Alameda</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e194-wk-Fact-1AD51D73207F5F368B67FD2FBF50B9C2">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e199-wk-Fact-FB2CEC7575C25398920E882786336C84">94502</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e212-wk-Fact-AE1F1691470C5352B96752E27C61E1D4">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e217-wk-Fact-1653AAFD9CEA547EAAD95A1CB52FAE15">837-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e229-wk-Fact-C13D1F2B53C35995A1BBF8ED6D545EFD">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e237-wk-Fact-617DE8D69BFD557B962C6471FC9106CB">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e245-wk-Fact-4C57964C4F0256A9A62F02015BB73513">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e254-wk-Fact-13C3E43844615BAC92A730C86126DBD3">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e296-wk-Fact-84F4BB7247395BE78194BF4CFDE7D473">Common Stock $.001 Par Value per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e301-wk-Fact-178448890F8651519B61D5E080700334">EXEL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e306-wk-Fact-0AE56F8C60FA53FEA85ADAED52A7A821">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q3FilingDateAug06"
      id="d8981987e315-wk-Fact-2CC65CA0F8815E1A93F186F2B01D7D37">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140714573050456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Aug. 06, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  06,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXELIXIS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000939767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock $.001 Par Value per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EXEL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3257395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1851 Harbor Bay Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alameda<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">837-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MEZ5JCS^%]RBYGQON_Q+%#U!+ P04    "  W@091EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( #>!!E$9117U-P$
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M'R:/6D;KW$JY]_!*MAQSCG^T_ %02P,$%     @ -X$&420>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( #>!!E%ED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    "  W@091YIV(2N\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  W@091
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( #>!!E&XJ2IH-P0  "\0   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  W@091
M@ZFE ]0!   R!@  #0              @ %[#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( #>!!E&7BKL<P    !,"   +              "  7H.  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( #>!!E$9117U-P$  "<"   /
M      "  6,/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  W@091)!Z;
MHJT   #X 0  &@              @ ''$   >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  W@09199!YDAD!  #/ P  $P
M    @ &L$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #V
%$@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="exel8-k20200630earning.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exelixis.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="exel8-k20200630earning.htm">exel8-k20200630earning.htm</File>
    <File>exel-20200806.xsd</File>
    <File>exel-20200806_cal.xml</File>
    <File>exel-20200806_def.xml</File>
    <File>exel-20200806_lab.xml</File>
    <File>exel-20200806_pre.xml</File>
    <File>exel20200630exhibit991.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>exellogo18q3a18.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "exel8-k20200630earning.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "exel-20200806_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "exel-20200806_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "exel8-k20200630earning.htm"
     ]
    },
    "labelLink": {
     "local": [
      "exel-20200806_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "exel-20200806_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "exel-20200806.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "exel",
   "nsuri": "http://www.exelixis.com/20200806",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exel8-k20200630earning.htm",
      "contextRef": "D2020Q3FilingDateAug06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.exelixis.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exel8-k20200630earning.htm",
      "contextRef": "D2020Q3FilingDateAug06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000939767-20-000116-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000939767-20-000116-xbrl.zip
M4$L#!!0    ( #>!!E'64E/H/P,  %P1   1    97AE;"TR,#(P,#@P-BYX
M<V3-6%U/VS 4?>=7>'EWTX!@M*)%&PP)B7T(AN!M<IV;UB*U,]NAZ;^?[29-
M^D%IDFKBH9)]?<_QN;9S?=V+RVP:HU>0B@D^\().UT/ J0@9'P^\QP?\Y>'J
M]M:['!Y=?,+X^>O]';H6-)T"U^A* M$0HAG3$_04@GI!D113]"3D"WLE&"]
MR#4R%?85G<"4(**U9*-4PXV0TVN(2!KK@9?RORF)6<0@-!)BL%.L.%2&-9%C
MT#_(%%1"* R\B=9)W_=GLUD',HA9QE2'BJE_W#WN=L^[9QXR87+5MX/[>\>,
MOZQX9R,9=X0<&\_NB6^'1T1!X9YM^,].G'?0Z_5\-[IT5>$V1T,;^,_?[Q[<
M0GG#(X3<PK%I(J1&?"/@B*B10RJIL9XGH Q'T,/= )\$'EHL^)V@1+OMS5$N
MC"K4@7R(M2J)<$G4,1H\Y->3<P@A;22D"H\)2>K+J (74G)+6SE2Q$WV9ZL>
MQ]564,,#LU50XS.S^5TQKC3A%-Z4LPFQ/5S@L#7AX+B=BO+KKJ>BP!U"1<\G
MDMJM-MM&-88LB0DG6LCYC>GOIRR6<H7E6TEB)?:LQ."LA43'S&%L[X+])551
M!]518UD*1.OY0RU]^P'X7'#,S>TH&=U/1A7Y8P$\H)IF2IK+J&[(J>N%>VY'
M!6 G/JTWI0+:&8M7GXJ4:SFWF>GSKI2F=@&+#BY9&JI)I32UU/S=#+LIIXI<
M]IIDUQ7:$%A]+07(-EHK@(Q.ZDM8HERKM0A.&%7OGI&W48MFZ^.A&+5T01T1
M!<8V< EN*$ GTK*=U]J,)<JU<(E?%T$X%]HQ65-A3!+&([&P&)N]+?O%E7D/
M$7)E<C^_L'87TWXB10)2,U/$5&IQ1S"1$ T\6]WCHJK_0TG<,>5WX;(QP>IE
M[BX' Z%I[(*X*T46##9=#CQE5CN&//+_'E0(4=V@#(1Q]H%CBLFH;DP& O$'
M#2>14#<< U'F_=OHX%F"W\8!,?/&O!+F;?^+C(V;M3_>W[[]_'4SEX""M> M
MC\VP:]ZIYH=P^6< 1@Z)+/3"7P>L4:4*PI]\Z-KKH>;@W&4'<.W;W!NW>ORW
MPG)CL9)Y_O+7$EANJ*2YA6611H='_P!02P,$%     @ -X$&4>R]=-@X 0
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M-1C+M>HF65I/$*A<,Z[FW60RQG?C_F"0W/9JG0N,7^Y'0_2@\Y4$Y5#? '7
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MH,(IQ@QF="7<B8A'??X16$O*U=]Y#VS.CAO=L00Y!7,JZU<>YP8MO)_)5U/
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M)^/1NY-PU1^EX[[)P@BF+F=%/A@6?2DI0I9R PC"T@H,'780*(0]E=B2_CQ
M/YWV_KA8-3?_T;Z U-#P4L81UY8R+*2E0GFN#<9. \%.8OJX[5Z>SK*[?+@8
M>H*2<N1=B'L_UY'\=Z7D?S^??E>[84DVW/H=SX*(N8!9.GQ[G7T]#1T+0J L
M+WKE10_ Y2#YPU:GGQJ3#1L8L^CGI!SJLWR9)AN_394/DRP?I7F8@JQ>-,B'
M1PQ=WG$ZS,*X>EOT-KPMIR*-=6=-4V+1\R!T5Z\W<G@UK?H<7M$'R' #M=%
M,ZVTY(:L4YAK#/K%FM$'\W@CJ*)*<BFH(-92**FT@"MFI*)<,AB7QL6>,>)
M+J_GC:68O8G<T)?CI=V9)7&57<V--LKZ<8?W5'4M3UZ^J.O)SAKF0O625B'V
MJ(SO)X/K/J8>0(H-!\HK'>#!B%GE+E025:WIS:B220&H0]:S "(FPC<$ H*Y
M=LPA3SLNZK68I%13O:HCK3E>UMVY$E?7%0UIH[ WNKRGLNO9\O*E75-WUC0A
MXL?K]:K#AAERWPL*.#."($8@%0@8M<ID9B&&L0/W9G2)*/)<4&<QI9QR1:UP
MA$"ML K,LL\U@B]4)4%64NJ*'\PC3:L^JG?G5\WAO:I5;8[T&R8<&?+K&?;R
M@&BH?\<DH(D358#AIL6X^/8IO1Z7:XAI\?O@)NT+J00- 2T/6<\(-HSS5>IK
M"BI/"G8&UXH(CRU$"!-*@9< 8L&5L$@9B737<X.%IN2[J*1451T6]0P[SHK.
MO8I#1:1-;8!BEP-[.-'(K)?'1#/Y64M)$PL)$W"4#R9GTU'Z\._T6UB:P!#.
M &ZA<!A1"[E:)3UBB,91XFET9B6C" F+.:"(8>6]X!X+KYB@")+GP<1253*7
ME01=L:"(-JTJ*;KTJQ8JJEO5'BR>F'"0%G4->RVXJ*U_BQ?-G*@.#'>3YM?C
MZ?6O>79??#'9S>U@^JUO 2  4(D5I! !8@F5JPHP84H3AXW=;2@$N9$@+*DT
MI$PB!0"PD-&PDH>*0/0\\%AI2Q;BDJ6Z6(34M+$J2+IWL!9.8LUK#RH[#3F(
MEF86OA; -.S%%F;:<*4*;"[2X5T>VH/H\O.XF*1]AS7C&#O+?9CN6$Z%7L_&
M$?"5ER];@1% 5.HPDS(04RR9\ Y#I+D-\*2F<ZS,123950+1/R__E:SD5>=)
MO%/'(=*I27'DB/6G#60\[?X>3M1VZ>7A4%]ZUD*65,? YWQ0G@^[^'9SF4WZ
MUDGB)%,,*8TMI=HSL<QL[JT751FP&=4;H<,"WW - 6542@<<"<LJ)0"CF/JN
M ; 0DRS45*_[2&N.%WUWKD16?#5#VBCTC2[OJ?)ZMKQ\B=?4G35-B/@QWCT,
MOX0$2.<;'8$;5-"0P909!1 1ROI5(B.@3.PXOQ%<0,<0-(I3XJB54EDM/06A
M=)1W1'<]UJ\T)2M1D=N4]0RK/MQWYE4< ")M:G/$?^S D5&_EEDOCX5F\G>,
M_@U\J+[KX,>3]/>[F\LT[W-7SC*<8)X3S0.3N%P]PN,"J\H'EK8"DZ 20RT,
M#("# $E%+!,2 T\ELH8_S_Y"*2A9*(K=4X@QJ>I&0D?^U-H]J&)->SL&WWM^
M<)N@AD$O#X'ZTK<V!&KWOWKQGTV'67Z;Y?-W;UP4@R(UV=VTR+^9;!20HYU5
MC%LAM,*!/8Z!U7*7 PAX' \.MV4A<L00XL/02H7WFAKEA J$,T) "IX'$1L:
M?TSF*D.^)$NE22DUEAT-/:Z*D^>SMQ9A&CG;'GH.NG201NWX^UH U5)OMIC5
MIDO5,?9Y\' V2L/EU7CQ1K0E-BV"Q&(DG+,::!=64QZLQVK.*A_D.MP*H-Y9
MKC!34%-OC0 & V>0I49X:>#SH"NH2S;EU9SKU#:S*JF>P\=:C(JWL#TP[3'E
M()*:&OE:8-2X'UL8:L>9Z@!2HU%(K]GRR_EXFL*^Q8YZ)1T45$(OF<9(+^M%
M. @CSWOL;,$K&F8.A@!/J+968A5JD0L!D#?6X^<!SU+2CZN+I!27?)A&3Y1J
MF5@5.EW[5PLX\=:U!YP=AAR$31,#7PMH&O5A"S+-'8D&C F7'_+/V?VT[S&W
MTG OJ0462J X9*O*T-#4P\NC^-QJ :C53I8[H!@+R12E2B@GA:'FF<Z=KBND
M5%:N%TIM-<$28UXD5CKRK1E4*EG6.E"^6U$%)S6,>V4PJ=.#?2BI[48T2.9+
MLP_YQSS[.@[][5M''-9"<:8)Q-*'!1E=%82 G-2BR=-&%(%2"VZ,]F&QAXRT
MRFL.)/*>2>*Z?N?+T_I8[T&L!-;D2K27D7#ITL9FA*GN8.N8>6)*%=;4]?&5
M :=V-_91IYDOT>CYF,V*P>0_X]OYEI#6SGNCL,8. &(XQ0RLB\7C>N#9; )Q
M3Y0Q4CEB*&-:&X:%MH@#&.9E[)F>/JV+9B$N">IJ;2?7<S$2.=T9V PX5;UK
M'3<;AE2!33T'7QEJ:G9B'VB:>%(%,^7T2>7I8!Y>"N"((IA"P+'!"FJ_WCF@
M"-JJ8-D(R@QP("SO+""*!J4*(2,X<8PY:B'N^I3+?$9?BHDD1YPQQUG1F2=Q
M=*AH1RL?J_.HQWO*OY8I+U_P]61G#9.A>E&7GRTX^?@EFZZ>A6M-G((,2^69
M() %=/CUEB!QE9]*;P7V%!,@#7-:>VJ=ET@I0G486(T3P+B.BWNN)YD+BGYR
M$V_2\2+OU)^X0H^PIHUB?]KS/05?VZ"7+_KZTK,6$J1Z\?^9CXLBG9KLYN9N
MNGR4,^L#BY#S "H/2/D94H"3U9M"I<>Z\CFUW=%%&!%)X!:VQ%+FE:8A1<(7
M@Y0EU':]7%B*2C9554=!3<N.\Z![M^*@$&E4&V#8:<$>.C2SZ^41T5!_UE;B
M1!QZSR;CX;@83Z]_&X3"&P\F?<PX,(AH0@WBW%B*S&H8E$3IR@= =H1V!B%"
MM!9*$ JM%T1 98474#)A5=?/1[XK2E:2(DZ[UW#J." Z-BF.#C'^M'+,?:OS
M>[C0P*67AT(3\5DKF5(=!Q_SM$1.&CHU_WC \C-H\P]75V&B8AS&%!LH=)B8
M.&&0"]/E9;);4?V@^X$F(&2:*:N$ >4GVD"-('6. P"X8<AW?2@L*.L-'TE+
M%MJ2N;CJH&CBX7%@/)-]<>"HYUP;"-EOQQZ4M.#?RR.EC4YDK>94;<2<S69W
M:?ZX24X1)8X10*PD"'DOP6I?7G*K7$W0;#=DF314$QE66YAZ#[17RLDPF&O/
ME*1=/UK=*IJ%PG:H4\/6:/9TZVA# L68V0&(MKRIAJ/ZEKXZ*#7HRGXT-?7G
M.Z >)\-YN'K_9O63\>+OH;Q_\W]02P,$%     @ -X$&43#GH720!@  "#4
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MS6.>L( [MN(?YXXUY,)EYT5V+GW?"0(Q,=C5L'A:A/\ VCJX 32+LHEW:36
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M8[%NWZRD7=.2]@9V]25U-W/)4BJ:I6B6\GSUH%R;82+EAF8BKZ?B+H4-(*O
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M.FRI2*O9J&RWXS?"33IGI_WE\KQ[^[^_PW>-Z@G[D#WRC]NJA5HKFMMN6D/
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M;$E?$*2!&0>!,J+-F])32AXOV9P%[^SF->J,02WR4>UU<4HKN<.( \&ZR+^
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M3CO#KS&8T0D=$8?->V1P<^=99X'%X0[ ?N%"\./"S=^3(-F8RR]+"9P> DZ
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M0*1<6YUL M;);!42HOOU-D<EN#N!I.A\_*3*[L_.Y")/H0M!!H1U@;2<:=_
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M!N! # .:*MZ;*EH5H]ZH::K05*&I(GVYTB@;=5/?%9HJ-%5DJ:)BE*==SW:
M*C9MB=P)G>0;E8T4*_213++!&^JES\?75QNYCS[76D:Y4MVD/2*OW'UO;0>'
M@:B5AM&HEC6B:D3=)J)NX&IIE@S3K&A$U8B:<T2M5XQ*:1U)-7>(NL_6\\Y,
M@3+LP^A@K;%-":YO&66[#;&@;!HU<QW3W"K(\\IT#XJW[CIV-HUFK:F14R-G
M'N__"GHU3(V=&COSB)UFRRB7UO$NY!4[-VQGK=1W07J]E2$UMWH3875W5;%R
MK654&^LD/JR])WEETMJHL-^87BT9Y;5B*32F:TQ_Y2:MEURR#3*H-NM&I;66
MWVW=#5L/>$TCFD;>BT9J-:-17\OEMU<TLJ9U>Q?4@\NQ\%4_!2PF[P6OSPW;
M [ZP[_#IL]P?^/19[@]\!W.6!QGQV)$!M48:2&D'*-G8!QOXT#+*Y;7\'MK"
MD!,*/@P\;1BUREHV88VG&D_?TE77-&IK)0)I1-6(^J:(6C-*U;U U'V.>+P6
M@>"^-:0^8ID>F*]$V_QCIUDU6I5U(L?SRBX/B2OF'KV:)F#7.M9TC5T:NU;[
M]<VZT=39X!J]MG0W5FMK&FUR+Z'MDY'Q1KC8>]I0;;WCON[<'CF>$X3HZ;L7
MN^0+?U,4K[6,1FL;X=BY4UZTEGW8B-X$24%' &I$WW=$-\MEHU'1+%UC^MYC
MNMDT6K6UBA[L&J:O9WG=I6P=N1"4=_"Y:,V*T:KJ+//#9,OY1\]JTR@WUZKD
MH='S(-$S/T'^%= &2[6MR,AYC.77B+U'?+?<:!EE<QM)7+D7;O>H*]&99\F1
M8'U?CA+15WH[6A!T$T&'-:.F"X(>#A/>641MF4:KJ<-C-:+NM/QKEIM&I;K1
M<J$[*?AJ'-]C'&_4C5IUK3IX.X7C>YRH?8;]5440,H>DY7T/-ZH9YEJ%!_+*
M70^)B>8>N>I&2S>3TLBU+7G2J#0UZ]+8M1WLJABEG;H8#]&@>1G"'L6"FL$\
M\=K$J?T-6_GI[\VR65ZK&_.NA:UH_?N@,;U9.HC@+(WE!XWEVPB!T3BN<3Q/
M.-XL;Z.A2.ZP?*]MJ11PT!-]Z8M83F<A__[J.-O\XV[)J+=VJ3>N-D[L$':U
M6D:CWM#8I;%K.T'6I363N31Z:?1Z1KNCDE&MK"/:Y5Y"VR/3ZI4O[YT &W&"
M[+9)T6U_]16S8C1UOQ>MF.\]HI=!/BAK1->(OO>(7C/*K8,P0FE$/VA$K]2,
M^GJ%XG<-T=>SMII;DMGIL^,!DL/357A\L\=Z(9X.8WW!T5;@:&T9]5RQG:S%
M+:@P/VP3Z+Q0;KUN-#= N4L@S>M5M <WCJ:[G:>[1LLH55_?L4_3G:8[37<O
MJK]5,ZIKE8[7A*<)3Q/>*SJ*5(VFN8[3.;>$MUH7? _KQW9Q=:H2LK'P63#D
MOGAM)]I]-@X=+.#Z]/7IZ],_3,#UZ>]SU[$O/'"L-])#\BZ&YTW*+A7+NY1T
M>NBJJR:)-R$)'4BO24*31)8D=BI^5I.$)HGMD\1:I;7S:WK<PYYYIXX;A<)^
M(PIZ?>C1>[D&5AUY?FANO<B3O,6$';*I1Y/=+I+=6L'WFNPTV6FR>XW2M5;5
M%4UVFNPTV;V"[*I[T?I@C\N\_"9P6F$7.$#$!X)9<C22G@HN"9B,PB#D'B[P
MM9$FF@7E'CY]EOL#GS[+_8'O8,[R($VK3\1T'$"#K$JI831+:\4FYTU,/&3M
M[" PM6R8S8TV"-*8JC%U*YA:-VKK%;_0F*HQ]4TQU30J];UPB>QSV/&3WO_]
M*6]8,9N&65VGK7!>V>,A<<$=0*^JT3)W*=1)H]=.H5?=:+5T"H)&KZUQKT9S
ME\+Y22+[%/*>*]+OZ5_ZA]Z9?LRLT'4\41B28^S8+)=^G-_Z>9$-/V>@^B,*
M0J<_F3W1])FX8EB%RI)M\H1B*3C-RU=8N?CO[$9M'NQ%F#)S/+DG^#F["$_Z
M(^[.S&F6%-K3H3)+N&[\ZS^.2D?T&:C-2CXOV<=;9R0"=B$>V+4<\07R?W#L
M< A_ O1QZ0/85I>/ W&<_'$RC\!'J=B?$KMY]+A2D)GBB:?>CB%FP+$$-E#>
M,-]06%=@(^PC4F OH5/U[]"?8L] %'J^X'<%WH>5'G/W@4^"H_<AX=*&"7@9
M'WL.2$O6'Q_DZM7N$&F.N#]P/+4\'H4R^4+A-7VS(>HMKZ3>6G-*O/._5<OY
M(^R-FP3HXX/"A9YT;1BM^UVXSG<G8#?"DI[-_AUQ'Y"0E4OE$OOJ>-RS'.ZR
M:Q%$;OA()?KWW*/-RTQ+-ND*0VP2V#<Z<FLKHRKF+?ML61S7:NR&D]D'U&Y'
M [@06-T@9,X)ZKZY7_X127K?KMS'5(2MWL.;Y<2_=[^=_7YV8["SBT[Q;06*
MC0+2N;PX[5[<=$\9_'5S^>WLM'T+'[ZTO[4O.EUV\TNW>\O@N_:NP'CT^8/C
ML7 H(WC&#C[NT+HCCT>V$PI[C44_CP,\PLEW2$3=D/S97"E_-LS'Y<^G?BJO
M]]HV)WM7$3FO<7RK2O._N1U@Q6X\S4%*"]8I]2..DY#I O>GY=B@2O@\=*0'
MSWD"EO"OR!-JBRNE@Q7'=@^59IHES%Y.N4&M4V&)44_X,7J9B%[F>GK/>P2G
M;#<"H,.#(0.9A3G>O0C"$1SD6^GP.D]KZ_6!C5JU9)B-O4C6RA51[GHBA*:]
M[=->I=DTZN6]B-;<YT1)Z=_![,SB8R?D[DM.ZQ4PYY;,YF#*#S65:Z;1:NHH
MF!VXES1=O!E=-.M-H[I3D:V'V+C[5L+-PG@0B)<I5Z\@I-T3\)Y[['DAO;)1
MJM9!P=H+ 4\K5YKV=HCV3*/9K!GUQCI&XMS1WAXK5^KB"T)IW0VE:PL_^.GO
MS;+9.&'BS\@))UJJS*54">15J1B5\B[)E5K;TG2Q?;JHP[736NO:R6>R!&<>
M'\$,0;79."TUFZ5JI?FUUJQ_:7]I5DJG[5:EV:C5S-HINO7Y+@2TO'VL]?JK
MI8][&N-UW>U<7G3.OIVU;\\N+]CE5_;/=ON*771O$;++\RZ[O607EQ>%^:]W
M!>:YF"^#B>^6&(?3%HZ,CT#*#'4TV#(X%M>]0_%@;Y>R8-97QHQ52WL3,S;_
MTYI+S"%D!QD-UWB'$*9=C'V['?I"L'-X>ABP+G YFV$X'*N4C,-4=#0&O1"#
M;ISOS\:?@V1%CT93)I;/-XFFC&<A$65ABEW$NW>-TWW!;FJTVS.T6QJ_JQF:
MQBS-T#3:[2+:K9F0L'^Q,F0.]$3(',^2(Z%=]GOBLJ_7C:9N3;CK\H<FO)TC
MO$;+*%77B9O6A*<)3Q/>*Z(%S)I1K50TY6G*TY3WMI17JQI-<R]ZS^QMI;FC
MSVT;:T-1QKGN0;CW\.FSW!_X]%GN#WP'<Y:;KNZR$PU>;C#UHM#C@<"3'HV%
M%Y#AF168+P+!?4M5?['%O7#E&"]C)K[C8R+80#U36'T0C1_9;BPBNA!,.!U@
M'!Y]_F!^_/D3C/"(3G( C93JAFEJX\TN\YW#P-.:859T)JS&T[SCJ6D:INZ@
MJ!$U]XC:6K.N1^[P=$T+UJZ+UX%P0;@=&&P@/.%C^0\0L[D]<CPG"#'ZXU[L
MHZ2=>[HR2VNZ0_/*YP^)G><>NUI&JZH;06KDV@[K:AJMM90LC5T:NYZ#769]
MERI^'*1!]XRB8EG(OS. 0%@ADWT6#@7C/<!\$#!3G^IK-:<5D=R[JUE]J!CU
MTEHEL5^[)5.4><V>; &K/FK[@J:2!2JI-&N:2C25:"IY@DKJ1J.I[Q)-)9I*
MGJ82L[66,?N@J&2/8STOI%=X16;?4G2H #K8,L(23UNI]_'>4=<O!3HOU-YH
M&95Z?1N0:CO6^X0Y:KK;!;IKE8Q&1=.=ICM-=V]K.*\T00E<JQ2])CQ->)KP
MUB:\1MTH5]:J*9%7PCO$%K1S>N&T@/)KLP*WO$>9*D0K,2A7S.T0C&T:-S1N
M:-S0N*%Q8R-;M&:/JIT(J?G" \=Z(R4H[SI WD3\4K&L8[5SQ2DU2;P_2:QC
MY-4DH4EB?TE"A\5KDM D,4,2M5W*0]ITI>N=4#Q.'3<*A?U&%+1[90>?JW+G
MA^9T@6M]<6FR>WNR6RM/09.=)CM-=J]1NM8*-M-DI\E.D]TKR*ZZ5KY1WLCN
ML)(=-A?4HKE.[N'39[D_\.FSW!_X#N8L#]*:^I9A'%K,S:F7.W=BKM8N-=GM
M%-E5UDIDTF2GR4Z3W6N,.MJ%H<E.D]V;!\GL12N ?8[.?]L@F;R35OXH:"W?
M>U[O)WT-:9+8 $FLXZ#3)*%)8G])8JU6-IHD-$GL+TG4=BF+:],>I5W0/'ZC
M9DG"+G  E0\$=G@:24^%<01,1F$0<@\7F/-")?GE-/L,N#Y]??KZ] \3<'WZ
M^VR2?"+29'_:055*#:-9:NR0C'H :ML^H5?9,)LZ:U^CUY;0JV[4UNKSK=%+
MH]<ST,LT*O5=\GP=9$CPD[[C ^@A7\&>GOO115YKDWN.J56C9>KJ&1I3\X^I
M=:/56J<HI<94C:EOS5,;S;W(HB'I]5/(>ZY(OZ=_,ZMQ'4\4AN2S.S;+I1_G
M]W]>8L7/&0BP;[;3G\P>:_J,XP%.AL?5)GRQR5.*MW=:WSF&?:T16TL&_']+
M_C>[P;2KS!*N&X/^CZ/2$7T& K&2S_%:YC=PR1YGEWOKC$3 +L0#NY8C[IVP
MQ0.?U4D>'#L<JFT^2I'UV2H,K.KH:9R8W:Q9$JZJ23>V]1_,%[5"A<6?K%C]
MXP37>@4B+EL[EC"P>#"$P:1U5^CQ0"#/'(V%%_#0D1X3W_%OP2+\I2]]1A4/
M?#&6 )4W8(['N&5)W^:>)=B#$PY9&SY''OUZ@YYS[ML!ZTC;Z<,VT*"W<NQ8
MK %J"]LP):C?<)AC)X17+0"RDX'GI[\WRV;YY ;!9=D?-DZ1Q57\C;XF/HA_
M_5?R7$_:D\]_^_G3,!RYG_\_4$L#!!0    ( #>!!E%*EY;V[AD  (/$   :
M    97AE;#@M:S(P,C P-C,P96%R;FEN9RYH=&WM75MWVSB2?I[Y%5CWSISD
MG$@B>*?C> [%2[>[TTG6=J9[]XTB(8D=BE1(RK;FUV\!)"7* B@[EAW'=G+B
M6"I<"W7YJ@"01_^ZFB7H@N1%G*7O#G!?.D D#;,H3B?O#CZ?^SWSX%_'?S_Z
MKU[OS^'I>^1FX6)&TA(Y.0E*$J'+N)RB/R)2?$'C/)NA/[+\2WP1]'I5I?GA
M* P520I'%I9':J0HHT /#5515%.1-2TTWUP=*I:E!99LF;JBJ4$X'A%%UK51
M0,9:$(PEO6ELW7M8][XH8)QU]VA5S,GFRSR>3$LD2[+4#*FB3TN8+\PY+=X=
M3,MR?C@87%Y>]B^5?I9/!MBRK,$5+7-0%3HLPBF)LK@W)E&:E615:1P4(U8E
MBHO!M4(#6<)63\(]!3?-C(M>G)8D)T7);Z)5@%.]&,][\2C;KEJ4LT%-%%0K
MNJH5_&IQV"O*:%7M:I0G_8*$_4EV,:B)M!J^5JV<YQWU:FKSCS9@;C80+O(<
MA&_9@R46-W2]%&<""0GX7 8"IWA8CA)^>4KA5)@L@IQ?@5(X%?(%OWB^X+&?
M<BI(D@X^ K7YQ^$CS+(0SK\0R$F8Y*1#4AB94S4.LIC?%Z7P^@(]B5/.^%A/
M%9&W1MDB+?-=HK%9B#9C<)OIK,ZIQK2S$ A53>0,.@WBL.#WQ4B\ 88"&P,$
M'OO3"P'WTPO1@+IYN%&$,\ BWZR\7K]<I(Y,9&F+W4)=E^@0[%6Q;BM3E^BP
M-(W!CN- L*CM$IPI+8I>D(=YEA".)+>(G*I1&,XS0:\53: UQ8BC:8W6 )$_
MS$D0S#<8WQYF0^3U&(Y[!6^9:8>,QM-2$B9AD(2*R)ZNZ#S&D+A;2EH%N-7G
M.0DI+-CP[*P%VK\L2=:@7I?!NO"F:@C[7I$Y*I$+5#;G:2Q5DW(YY\G-BL3S
M( 1*B+JIIL>Q#2''HM?6(>19\PW?*N3%]5)=#>UVXWR;L=$'K-8-1@*E. T%
MN8 '0. 4)U?AE-\7I7 J9.%\+/"VC-0QM^XY"<WW#M,M-MM<*U 3N"XWBL<Q
M* F$!KUYD'.0ZU81OL!S>^U48=RAPP(%!B[T1)I8T81HA#? %1KA#93,_A+X
M74KA]0,#*!;S>2@>'R/S^OJZB,NEH#=&X^G^E8B!6 'M3^*4T'AN/3S1N'AR
M 39T)+#OE,2;0R2R1)3"J2"*M+C!%?4+G4Z#+]^ VT8<!U=#NA'/*DU%TYAR
M9T&;$<=[(YYD@5,6HPHAI!!$(Q$O%B$B@TBX!K&-J<4>8;,0S_[4>"K+PLMN
MQ$5+"*"%&%3P/.9<L+A X.*=JOMB,9MFB:#JM4(="$CN!D RSY.4TR0.!)I5
M$P4FC$QF8A,&Q*[Y3K.\O,&,FV+\$0A[YTEK/!7!7Z!P]5ND1932,;?=TQ+,
M*%W,^/8S*O,!A6@#*$'R.&PJ7(%%_2+.*%'J=4Q^/8[9PN7B_,9(X$9&//]!
M$S;=P=>Z ">K0V%/=\S5+L'3PU P6B#PBHNTEBMYXWEO$78F+AB99P87@KP%
M$/@^1NA?>*ASSF\\X$%4JJ0YB3M0"*7R_<LLX\&KVL-0H@",0(N\),P:+/'3
M,%MBWH9FRH"21T%!VCV%:32.!0YJ3><"1T$E7N%5)+ [:A''NY$P5UH1^4LP
MGB8"HUT3^1AJ+L90<UZ5)OH5ZF&K !]8",+.AB)@"C?%U#"%GV:J*%&<<^S\
MNB:E\XQ;D8W' OM&28*@K=O&M4OP7*_ %G1D,#MFMZ)S*M-1Q1T:!&I7!FE(
MKKNRK"RFW:Z,EA"82+%<5T2>@ J,-M=FIUEZ X\)(>(UKPFB7HP$EK*B<>%#
MD<T%IJNB<=,G8T*UGPA97\>5JX*K,0IC7V'$6SMPH6<79(4$N']%Z@#G.S/B
M_*0 N2+)!D/H%_%57/3#C&)&8(LIZ:M5)N4N[D&1+1NPPP3P%BM)13$*(_'B
M18% E#RN-0"K$WWQK>@Z.[XC4RB.A$#"A&S4J?QM>*0N_O&Y1]U IX\0S$Q@
M E.N"02_+48>#97G+N/QA2CFIB1^6 0:>24P$PU5X(5X":&&??R$$(S]XJMX
M7A=?A=D=3@BVSNWP0C#FE+IA-7^M1'"*#Z.F)!3%9Y3$6Z4L%(%*H'!=(L==
M5+Z0&Y+0_8,NK,7?EX[3L RN!%-G-$ZE^5R02@)"AT7=F>K@*W=\!?B+A!L*
MWM1<I]T&91ZDQ3C+9RQS2MO1>I*Y,8Q4X!:KXH(8KW/7OH4-\=:H^29IUY#E
MGKQR#]4VJ! (\^,)(O+DA.O&Z?:>8() X6STQ<%$M 4"%)ZX!()4*Q#XC!<R
MG,/H,A:AB8;"BR5#(@!CE-+AWP@5U$]9G I2__QR/-\@L ;<W'C!2W(SQ>:G
MMZF9Z\;M_$'%$0\ML:6-^,%,E63OC'LKND##.C,H_.S)5<)7+(;U_WS?2@OE
M9)()?!PC":!]F(B.4E1$KHD3) LKT,?/3G3E)OCQ[82(3!BC=85QPOV^=@F>
MG)+)COW?&J5.VAM'1)0(XKE&VEQ4;HZN;ET;5,2#X[__[6A*@@C^_]O1C)0!
MHJ5[=+,&0FDG2TLZA7,(B@Y06'UZ=U"2JW)0G3P;L(IE7";DN#GR=C2H/D/3
M@[KMHU$6+8^/HO@"%>4R@24:0V.]<3"+D^7A>3PC!?I +M%I-@O2MXQ6Q/\A
MAUB:EV]AD.V:,-]Y$BQI)$<.CH_BJT/:"<FK7^,H(BG[%>@?JABN&OE5>4KA
MK$MCA?]1_!C<Q<0%YMJ+"0T<TF!&&R?QH0V3B.A$_"28'* 8%LD/PK*G2GAH
MZ=BV=<O4/-\8NE@S#!UC;$NNI@][EU]Z-RIX@"KG].X O-GA*(.%#M)QD!0P
M'_;?T6!C_'>;CI?"<BP=:CF#Y"2-R-5O9-F:EF;:#O8DW9*'EB8YANG+IF&J
MKJ1CQ\".LYK6KH('QQ+\L13+T(VM&0PV%V<5NQ;'1S03QY('LP"FA%@&^G#*
M8@\:Y/6:X*Y_55!%8&0:IK\[*.+9/*%",-ALH^JNW0?[6&2+G'UBF8W#FHV,
M$P(V,NFN2A/&1OI%\PW8;OAN'),<L9X)%THY)[]M,N9Z9=;'X'HG=1]SX%X6
MM7LM2G"]=(3'=,@4BDEZ4WU-:U4 8184;RBM :SZ:[ZHF=1P=,7"04OOP 1=
M,.4^/@H8-PO'UBQ)LC4/&X;FJ]@TL*]XUE!3=<]Q'$R7+-BHV%)PBN-Z4T)/
MQ1YB6?K'MCTX*N9!RK,D<0HA5EQR:HSR ?1'ZS7=MCJOB#O',0\B>MBX5V;S
M0W5^]98R!IQI/$D/0T)/Q+;[U;M'ZD"]41Z_*0"J @S/X_'URNSC9=7]*$LB
M:.WSAY-SST5GY_:Y=[8YFZYQ/_@XSSSG\^G)^8EWANP/+O+^='ZQ/_SL(>?C
M[[^?G)V=?/RPI\'+=QF\S!_\'T$QA54NL_0-<OM.'\F2IEIW&3#[)DZIQA]*
M(#?;W&^UUPA90L95Z>NUVQVFU(\D&X*):1EHL@Q&"4$A29*:^NY .F"?82)A
M\_GVWG@6Y!,( -CP@D69-5^P4^S5-Y=Q5$X/95V'D8RR'&Q$+\R2))@7Y+#Y
MI<TFVA8;,MB2,@+W1H<(B$RF9J*,Z(]\1:U'7/6!%:6:+2O63>4T<D'R,@Z#
MI!['#/Q30IHAC[*RS&:'>'Z%BBR)(_23Q/Z\W5@A&7IHL[_]N6ZA_57%)7G-
M&+9D6UWP1:)IO\4ZUMY]J[/_\?1W=,UX;O+[QV<DD\%[YN-1Q<%-,$?]961:
M)K9,@UCJ"FW)CJH!*L&2;MN:[OG@/'T-JYIJRJ:G8[,-\1KDW<+IW?#PV.S]
MM@W1Z@7>6F>F.0-F4+:<YXV<I;[+6>YPZ]W<EOC<!A=TZGTX1Z?>IX^GYVA/
M'N<^1OKI\^G99QN&>OX1@>L\!_^(L((^GB*LO8I>HX\^.O_%>\PS:#G\E;.W
MG7,Z<FPIZBV&ON'*Y.\A-U1+4#9&IV2>Y25ZU7PF >!A4I2(7-![73DCD^CU
MX6IV>QW&T7:;E].X)#WJO@DH[F4>S \ZK0D&M-^8$P6[CN3(ACETAYKEZR8>
M>D.+@G)'MH>RRS,GGU@PX%51PHWLRD9@&\'7,Z@SC8+E$KA'TH-C*+8 %NIO
MV'VW729HGP#W:4(LXXX0"^^$6!6,NS6(>G#?OBT#5#EF$U3D895(2+))ALVO
M2H#-_E_SR0$*DE) J=NL14"U8"@UI%3-FAO0]+:3?#C.W!C8/$S$MQO:8-E8
M&2,#NY*O28:J:ECS;,NT[:$OFXJO^%@U7$[ZZI1,XH+NZY0?@'(SC./]Z;T_
M^?/D[ TZ^>#T;PEW'D^@L$O,UXMCWF%AJ[JOO"M8'\9]ZO+R%==14*!B3D*:
ML8I0G**X+% X#< #YJ_W 1FE.\*6VV1^[@J=GJ(K80MP%T^B[/0DBOH/8:BN
M*#>C[=9-X.JM%0_?PL2VJCPX-+V!E=7PRLI*KJ78JJMK,M8T6Y=,7?)M"[O8
M43Q/<Y1M*WN2AED.L);MFY^58$J=Z@B!DT6W!X#T= %-29=DGF<7M"^* %V2
M!)< !F]NC_>ZU+?QIH]]J?754EM8<I6A+KFR[&B>ZMM8<S33=0W35UW%M[:7
M&A:.0+,CDM_,F8(_ZRF2K&C?:=V>D(KJ:Q55?6P/3<MV74W3)%NS75U1?$W!
MSA ^8VE[W<Z#JY-ZZZBZRWBK151[BJP9BG6+5;P?B[LW-6S[6WDCM[X'-,1,
M(,IR])$>W4._+O*XB.*0LIW"HPUSR4-!SY!E3C:;Q05]1 ^B)@95XOG"',:<
MD],SY,WF2;8$:=I48_0AZ^\%2-__GMF]8.K=9M-4UO&CBH=#!4)'U[8TL&:F
M9QNZK-JR/M1-^+MM-NTHRDE1U/^]AQ'BFYG,6_-ITQU@4\/HER '9(V&P1)]
M"O(OE\%RQ3N^%=ZK1[J'O/&.A;)6"V5JNJX"_O!4'2"H[PQMU<2:Y1C8=@"=
MJL*%<N#7C_EY=ID^R#+9"0PC"AYR6=YLI(V[.=K:%L*VJV'74&3)\#5?T<VA
M;OBN[ ]]31I:CBSD*/-E'_-/ ,5C=F=D+VC^CGRGI:"/-'Y0UM^&\VM9]H>R
MXSF&9FB.#$;'M&3),TW9, &RZ8XIEN5/&; M^;]X?N,HZJYLM51-DG] &[,'
M%UOSG,*S>0Z"'L^#!)$K$B[*^((FM<#ADN(U>@7K@>B"O'XLVVKWYE;WMLJO
M;JPW,I97>F-[V,>ZA55#<C1%DX>6;FBR)QN.CCWL;N@--?MV3H('TQ1=DQY2
M3U[?W/3(>)TOQ[JFV+;O6HYG:ZKAV;9K:38-$F4?V*NU6?@^ R3]:9JEMPKO
M[\A&4S%ZAB0]*"\?C\U9;T[\\R<3UNUM@4J2D#E=!)2R57B#P!8E"QI_H  $
M'!8%3,^>]L592G8C<%$W3YGMP38Y4Q)^01 &HV .  !L*PV-1]D5&I$DNT3Q
MF!%]  S([/V&QDS"4%P@^JQ0&%:$R@P5\6R1E$%*LD61+%$!H4\Q7K*:=85L
M!%,*F@B;$EJ;$ MH)T=!NFQHXRR!SFD]"DIB&G86Z%5!"/J9I"0'TW^20MU%
M%;+;?;E?#;>U:?]PK.]6=WF--!RLN-B7AYKB*)I%-7TX]$W/U5U-U3Q_8Z_^
MCSPN@;\T[%ZD=2Q9?!NXHP?11P$PM(1E[1 7&]8^09^A-Y!A]/L9S.^?/UF&
MJK[]1O47[]W<V6X<'-<, HZT.83FB[Q84)D"J3Q=) 2ILE;+%Q6L,P ,4#$F
M!;+#$KW"!G+\4R0K4A\*?@_%[98>9>TL=&RXGNGJUM!W-<T =RL[NFI@W[&P
MI#O#MO2<94D<PC33R>\@%W1=7T1GW<::.VA6LV=;;K :]+#<$AWO*IP&Z81L
M"HXJ]:N2CT]V5&V=CW8TP])51_4E6=-MR]9E^$W"VG!H*!K>V#+ZE!-J=>@%
M"W;VD!KY_.-X?$/(\4QD"+C4"UMLVFF'L!KUY%>CUS>3J*KLXY,IK96Q "_F
MJ8JIJCK(D>U8LFTHDF/J6-;=H=LE4R=%L2#YBV3M2;(4TE-?A3>3K+KL;23K
MX0]KW.I"SAY < L55*B4Y(!KVXR&$I3[__P)Z]);S/2XAJK X<-OBEBVE%+B
MZN0/="BE.M9AZ7U=UBU3Q=5/Y=[/GUCB,R8R%M-4Z3;G3ZK=I0<_^W5W\6:M
M1R2L]S,/F96@D@+-GM,+O=4AZ'"*PB0HBMOLZ#U-GN0!"^?/EK-1EKPJ;K7'
M^20Y\J$^-LB$A#2N!0+ORVD,WZQ-YJ,Z9O (CXC(UOIHCZGZ*J!O6:7'-H:>
M 274H:\ZONL9+GRY$<Y5_FF)Y1'3V)OE_BCB@D4Z*[/P"_KOOB1ANDV)_ATD
M"X+F@!3.IH_[O-8C7$%%6A_RP09@7].T)-_4-:QA:ZAC5_,D4S(D2=G<!*V-
M2F53;G[,^65Q;K<X:_62;$_3?=.A9R,UQ?=L4[-=VW,UB%)L4\8\]6I0\XV/
MHF]%)-0X-ENHYP ./P1%%'RM5?#W(/]"2O3^O7//5_0ZKC]^U]VLA\AGGZ01
MC90(&BU1R'+;,V [>"K"CGI=2SS'!8*N(,RBAZ<G:))GE^64!EQSFHP."A21
M,4R(G8ROLHF2U@#_:ZE$^!9;BH)>T1C!>,LRBDWAF)VIG],S]?34616UR:.>
MS&EK(W2K&E57C=((;EVOU6P?>?Q)?',H>_,=+05KK=NMCJXY-IA$$VL>MBW%
MQZ;NRT,)NX:K&-N;Z<VX?V;#=JI1/Y5\P&WWLKY-+^[ACL1?BZ*,Q\M[U]9Q
MA_[1O36N,L=;&TA34%620(P.JIIF+&)?%(25@@G4VU3TZ7$QVS"JGH9"Y8?U
ME2QIY^PU@E3M4XAO@9*3B[B >F  @C2D$A.$[,E[M#!]0FX4Y%%1;5!%_'0!
MPLJK8)4I:&MV?S]Z>2/IWFKBNK!_OPS0]4>T?+_GQ4SS=99E0GJCG 1?>L$8
M;.MAD%P&RX)F"J;YYN-P/%_19$FA5V\]S37MX=#"MC_TAX:!O:%E_9B/PZ&V
MM =JDX-!/RP6,]"YY7V#NY.2S)#<E^0^0J>D6"0E.^KS$32U3GN"OB%_I8I.
M!J:!$OKWE"%G]T'W:^P^IGNX4=Y<M:XRD:O[UG=O]@W8I^K)RV_H ?@^Q1RF
M+$MOFZ_91_SV-8"F8@'V+@#31T]DY82^TI'  J5@'4-V.@!6;VTV\WH]J;FE
M=O#K@ETO1)59WL?8?UTDRXHARCX90D6N,N_L> =J;@40M)C32_!]9,-W<W9J
MH5B$TVL, 7@V7N1I7$QAFO01P96'H1!O&H_B$EE6'[-.V&F*5>M584"<X/56
MSSKKW]=6T#T(.HU\XG3UH%8*GAE8K1ZMT#XR4SGHBAMTTF7V!A53@'#,BX\(
MX&\ !Q&J17$<)R2JY9")$_C<>5809BLV4_3F#:'U&[H@P8S)XAOJ]MG3G"_!
M\\.2COZ"-JD_IPW1=]\  F4ML;:#$A6UGX=Z=?<%PM6:8AE<_ROY=7>XT.Z^
MCZXSCH+@H(D_6BRLA":MCNV$-5RB_&QXN<'##=%JRQ0]PI,QR%,?TF$"2AO]
MW#_KMT=,^UMQKW459!9$#)RM34<3:%44 G-A%VV8)V5-4\5A:YV-WU (!R J
MJ0]VTI%,ZO,]<?L.#DJ@XP7X93IIIFG5@&^C%-\U"'X([VGU)0S><^TCV<EP
MNH/8K!^3C>(6'O,I\XP^@*>R%=L_OX%5UTWLSKVZ)[#3=^>[Y=K.O3TLB??O
M.K;VE&^KIIG?L"/XU)X6P=&5!K!4)X\?R7Y8!EV-D^RR?OSL/L*G2ON_87[/
M2 9<4H1Y/*=N^440'H4@/.3\O^O3D.[[&!"-QUYD^D&6<GL^P<8J<T\B &[(
M\D.F2KZ_F::J Y^W!VC]@''V?'%=D6J:9>'^M)S=448^L1#_=!7BLU3(YM/O
MUJ@Q>)&C)S2_IWJ4Y> 80^1X\N'L&:[I]US*>]B;IZ])8E>CZ/L;T?K%'2_K
M^F.O*TT,LK5MWLV)HGIMX1<(U&FF+YC/29 W:<$3:B; ,]++T6Y0!M536T8D
M#.C&*$W0L_;*8%+0BXN(0&07T7P\S0&NVJ!NMRK8]-=_=H;QS/GE18%^= 5J
MB_)Y<)6EV8QFK4N2LCSV&7O#S(O!?+KS>]HVRK'?/\,U?5XV"IH(%TFU'_:^
M?LG]B\5ZNO-[VA;+]?QGN*;/RV*Y]/!T_&*PGLG\GK;!>F\/G^&:/B^#]3X8
MD:1X,5;/8'Y/VUA].O6>X9H^+V-%=R)!?EX"PN<ROZ=LLM1GN)Y/S%PYE'?H
M$SVES=U\>EGA'WV%?78Q@=XB"(J-S4%ZO'SCKD)S6)!BD5O>:O_!KP0.E:'J
M699MZ$-#<UW-&KJV1A_I+NF6Z9CFCWDE\.%?/'OR\P?[_/.I=_8#W7OZU+H!
M7%U0_KJ(\_H*QDVO(W%N-D>+9(G8QGVT<0L(NAD15,#T@)!5[^X;D6F0C.F=
M'-H0.SM7%Z!W;A;TP@]K+EB4TRR'P4>WN433]8;R>[K%T.JR-\O^4YF^M_=^
MM\' ?54V-0/7/V_S%+/NE_.Q%YQ>OPFA[KP)(9OB>PO?1M+T1_+\LT?ADI_.
M_%9")1\\_%SO%X&LLAK??+/AX'CU]MA]7!(^V<. V$MLOR':>T");7S [7SF
MCZF=+W-]F>O]IFD>Z6NF]V&@.QY.\<C$X:F+^W>9WW>4[&M5[O\EL0?'@V*
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M+LR%.PH.S>M)5C1(0#.IFIEI2[PK##2B)2 :&XZ&N$26:T)JH:&Z\6H-1)E
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MU?+Y!X]CR-K$*\EQD:Z?]_E[[S ]E)A7OF)S[/(I=VTVUD+/-)<E?[/?']Z
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M6O4].<N=PTZ:F!A>--Q[XK7CICDV =6?RM 7)LC1P\VAC+C+L(YZ:Z.GVH_
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M\7DF0(3)A6YNJF;EHP+)9W8^2[+'R;HDG#7'KZI_4_]:,9.C,3^\'5<'(U[
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M/OZ#ZDU__D>.!/R=IQ#9UM/D;#0>0XN%[D/U/VAG EHI)Z#)\Q)))3>>_YF
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M2N$RQB&4$^ZO(";T4+>0<R)7S\."LQ/#=FS%*A45O.94'QA;U=@@;US/M[8
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M3H#*_0@SZ"$4  +J*#\4AU4,DC6_ *>B5FB4*\G:D6PUFORZH*50D86,(@&
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M=+(CVK%[95%[R/>^MF3,1=!7;)@^U\151/KLG<?[J#S^P /:,:JOX9;PB]$
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ML,,9(_WL4$*)LW\2#!"."9NU#W]92Z-E5N](2MW8B8*^XJJL7 \):??*DO+
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M^NT^77!A*[2MP3EY@>/3YG#$D/:G0=YS()MW#EM74W*&.?"='Y:?H0AZD%#
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MT\V=VHA:]>6^%&E^#)")#ZJY_].PD $B"V7\6 ^M/M&(/5CBX+L%]K/>?T<
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M:PXF+X'MZ1,(^UF+Y=_I^;$]6N@7;?2J 7<7<+I$U DY]*9@,.UP"9[KH[/
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M+V-OLF_-MH%4NCAJ'7!PS0DT_LH[@S0&Z)'!:( [P)I'S;=&*K9:_. LY(3
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MCHE ?GH>8X7&M"NKKEHVO_Y*)NE4+H&G&_7(*:!SH*5TRTRB?Y^)7?]\BS=
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MSV_I/KJ_>X(!,7MJAI >X%F:(,OG$:4^</GS^\NO6L[L]$';V9<YR9?O0M#
M )0](AQTO.YB.)ZOJ4^B>>L!5\,R8 [66\2R/$^VZR+)TV;<A_RQ2HY5?_)
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MPW:8]T,WDK4RPZ22MN2.IV IBC-G'".C(<+*^SXM72\]K"R<*G+J_ CIY ^
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M7QQCQYUJSZ4"K+&I%#1]"LQ1DQ8?FJV.KCK-HGC\] P/,4]M/Z8"AA;RC:B
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MD2(!J^/+-_6&LN)?MW'8 )D'QIT+V]!TD% : "G3H!/93$"5>)T*^Y@\[=*
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MS]VX0X^%DU@D*8</3P('Q^_4X/7KAXU73WJ=B)4J_?H.47RW)V3_3,S9#G[
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M6K U-H'S==JKBF!]'8EK] $,2[:WSN_'T@)=7PH#$I>*K319X#T=# E)V&A
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MRMI :&PY,8G/'U_ _!AX8F3625G+-,RP8K\LW,4:L>WJ_N3!#0
M        ^*>S-8G_!U!+ 0(4 Q0    ( #>!!E'64E/H/P,  %P1   1
M          "  0    !E>&5L+3(P,C P.# V+GAS9%!+ 0(4 Q0    ( #>!
M!E'LO738. $  &P"   5              "  6X#  !E>&5L+3(P,C P.# V
M7V-A;"YX;6Q02P$"% ,4    "  W@091?.&V\IT!  "^!0  %0
M    @ '9!   97AE;"TR,#(P,#@P-E]D968N>&UL4$L! A0#%     @ -X$&
M42S,,,> "P  (V8  !4              ( !J08  &5X96PM,C R,# X,#9?
M;&%B+GAM;%!+ 0(4 Q0    ( #>!!E$PYZ%TD 8   @U   5
M  "  5P2  !E>&5L+3(P,C P.# V7W!R92YX;6Q02P$"% ,4    "  W@091
M<!=E?$4^  !/=P, &@              @ $?&0  97AE;#(P,C P-C,P97AH
M:6)I=#DY,2YH=&U02P$"% ,4    "  W@0912I>6]NX9  "#Q   &@
M        @ &<5P  97AE;#@M:S(P,C P-C,P96%R;FEN9RYH=&U02P$"% ,4
M    "  W@0918=$JD5D1 0#"Q@$ $P              @ '"<0  97AE;&QO
C9V\Q.'$S83$X+FIP9U!+!08     "  ( !P"  !,@P$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
